| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.869 | 0.002 | 0.869 | Antibacterial | 0.263 0.165 DBMET00328 0.343 0.106 DBMET00484 | ||
| 0.769 | 0.001 | 0.769 | Cell wall synthesis inhibitor | 0.148 0.068 DBMET00328 0.261 0.014 DBMET00484 | ||
| 0.602 | 0.007 | 0.602 | DNA synthesis inhibitor | 0.359 0.028 DBMET00328 0.401 0.021 DBMET00484 | ||
| 0.526 | 0.069 | 0.526 | Beta lactamase inhibitor | |||
| 0.398 | 0.047 | 0.398 | Streptokinase A inhibitor | |||
| 0.322 | 0.019 | 0.322 | DNA methyltransferase I inhibitor | 0.277 0.036 DBMET00484 | ||
| 0.288 | 0.008 | 0.288 | Antibacterial (Helicobacter pylori) | 0.149 0.047 DBMET00484 | ||
| 0.283 | 0.033 | 0.283 | DNA methylase inhibitor | 0.262 0.042 DBMET00484 | ||
| 0.27 | 0.026 | 0.27 | Amyloid beta precursor protein antagonist | 0.159 0.092 DBMET00328 0.147 0.104 DBMET00484 | ||
| 0.309 | 0.097 | 0.309 | Thioredoxin glutathione reductase inhibitor | |||
| 0.17 | 0.005 | 0.17 | Elastase 1 inhibitor | 0.12 0.012 DBMET00328 0.129 0.009 DBMET00484 | ||
| 0.151 | 0.005 | 0.151 | Elastase inhibitor | 0.049 0.043 DBMET00484 | ||
| 0.186 | 0.054 | 0.315 | Phospholipase C inhibitor | 0.184 0.057 DBMET00328 0.315 0.017 DBMET00484 | DBMET00484 | |
| 0.115 | 0.037 | 0.115 | Acetylcholine M3 receptor agonist | |||
| 0.078 | 0.002 | 0.078 | Elastase 3A inhibitor | 0.031 0.02 DBMET00328 0.046 0.005 DBMET00484 | ||
| 0.078 | 0.002 | 0.078 | Elastase 3B inhibitor | 0.031 0.02 DBMET00328 0.046 0.005 DBMET00484 | ||
| 0.078 | 0.002 | 0.078 | Elastase 2B inhibitor | 0.031 0.02 DBMET00328 0.046 0.005 DBMET00484 | ||
| 0.078 | 0.013 | 0.078 | Leukocyte elastase inhibitor | 0.044 0.028 DBMET00328 0.067 0.015 DBMET00484 | ||
| 0.121 | 0.066 | 0.121 | Topoisomerase II inhibitor | |||
| 0.087 | 0.056 | 0.12 | Transcription factor NF kappa B stimulant | 0.12 0.025 DBMET00484 | DBMET00484 | |
| 0.038 | 0.007 | 0.038 | Elastase 2 inhibitor | 0.021 0.016 DBMET00328 0.027 0.011 DBMET00484 | ||
| 0.038 | 0.007 | 0.038 | Elastase 2A inhibitor | 0.021 0.016 DBMET00328 0.027 0.011 DBMET00484 | ||
| 0.004 | 0.001 | 0.004 | Antibiotic Penicillin-like | |||
| 0.055 | 0.077 | 0.075 | Antineoplastic antibiotic | 0.075 0.061 DBMET00484 | DBMET00484 | |
| 0.186 | 0.211 | 0.427 | Immunosuppressant | 0.427 0.054 DBMET00484 | DBMET00484 | |
| 0.061 | 0.097 | 0.135 | Chymotrypsin inhibitor | 0.135 0.021 DBMET00328 | DBMET00328 | |
| 0.04 | 0.077 | 0.5 | Cathepsin B inhibitor | 0.5 0.003 DBMET00328 | DBMET00328 | |
| 0.038 | 0.077 | 0.066 | Neuraminidase inhibitor | 0.066 0.037 DBMET00484 | DBMET00484 | |
| 0.124 | 0.187 | 0.265 | Free radical scavenger | 0.265 0.063 DBMET00484 | DBMET00484 | |
| 0.038 | 0.108 | 0.074 | Angiotensin-converting enzyme inhibitor | 0.074 0.017 DBMET00484 | DBMET00484 | |
| 0.066 | 0.138 | 0.158 | Interleukin 1 beta converting enzyme inhibitor | 0.146 0.019 DBMET00328 0.158 0.014 DBMET00484 | DBMET00484 | |
| 0.078 | 0.151 | 0.534 | Factor V inhibitor | 0.534 0.001 DBMET00328 0.1 0.069 DBMET00484 | DBMET00328 | |
| 0.043 | 0.12 | 0.211 | Caspase 9 inhibitor | 0.211 0.004 DBMET00328 0.112 0.011 DBMET00484 | DBMET00328 | |
| 0.04 | 0.119 | 0.073 | Neuraminidase (influenza) inhibitor | 0.073 0.031 DBMET00484 | DBMET00484 | |
| 0.023 | 0.116 | 0.054 | Neuraminidase (Influenza A) inhibitor | 0.054 0.019 DBMET00484 | DBMET00484 | |
| 0.009 | 0.108 | 0.62 | Calpain 1 inhibitor | 0.62 0.002 DBMET00328 | DBMET00328 | |
| 0.022 | 0.128 | 0.173 | Protein 50S ribosomal subunit inhibitor | 0.173 0.005 DBMET00328 0.053 0.037 DBMET00484 | DBMET00328 | |
| 0.079 | 0.188 | 0.136 | Acetylcholine M1 receptor antagonist | 0.136 0.089 DBMET00484 | DBMET00484 | |
| 0.053 | 0.166 | 0.122 | Factor XII inhibitor | 0.122 0.023 DBMET00328 | DBMET00328 | |
| 0.023 | 0.136 | 0.062 | Microtubule stabilization | 0.062 0.012 DBMET00484 | DBMET00484 | |
| 0.004 | 0.12 | 0.019 | Neutral endopeptidase inhibitor | 0.019 0.017 DBMET00484 | DBMET00484 | |
| 0.131 | 0.255 | 0.397 | RNA-directed DNA polymerase inhibitor | 0.277 0.037 DBMET00328 0.397 0.018 DBMET00484 | DBMET00484 | |
| 0.055 | 0.194 | 0.194 | Alkylator | 0.137 0.054 DBMET00328 0.194 0.028 DBMET00484 | DBMET00484 | |
| 0.138 | 0.281 | 0.344 | Insulysin inhibitor | 0.265 0.083 DBMET00328 0.344 0.036 DBMET00484 | DBMET00484 | |
| 0.176 | 0.321 | 0.424 | Calcium channel L-type activator | 0.424 0.066 DBMET00484 | DBMET00484 | |
| 0.047 | 0.198 | 0.247 | Chelator | 0.247 0.017 DBMET00484 | DBMET00484 | |
| 0.08 | 0.238 | 0.416 | Growth hormone agonist | 0.416 0.014 DBMET00484 | DBMET00484 | |
| 0.02 | 0.18 | 0.073 | Glutamate (mGluR8) antagonist | 0.073 0.004 DBMET00484 | DBMET00484 | |
| 0.076 | 0.246 | 0.155 | Dual specificity phosphatase inhibitor | 0.155 0.088 DBMET00484 | DBMET00484 | |
| 0.056 | 0.229 | 0.448 | 3C-Like protease (SARS coronavirus) inhibitor | 0.448 0.002 DBMET00328 | DBMET00328 | |
| 0.067 | 0.241 | 0.164 | Dual specificity phosphatase 3 inhibitor | 0.164 0.085 DBMET00484 | DBMET00484 | |
| 0.003 | 0.178 | 0.073 | 3C-Like protease (MERS coronavirus) inhibitor | 0.073 0.001 DBMET00328 | DBMET00328 | |
| 0.112 | 0.289 | 0.406 | Calpain 2 inhibitor | 0.406 0.058 DBMET00328 0.217 0.173 DBMET00484 | DBMET00328 | |
| 0.04 | 0.222 | 0.111 | ATPase (Vacuolar H+) inhibitor | 0.111 0.027 DBMET00484 | DBMET00484 | |
| 0.021 | 0.21 | 0.081 | Nitric oxide donor | 0.081 0.022 DBMET00484 | DBMET00484 | |
| 0.008 | 0.198 | 0.034 | Retinoic acid receptor agonist | 0.034 0.008 DBMET00484 | DBMET00484 | |
| 0.035 | 0.227 | 0.13 | Protease inhibitor | 0.13 0.041 DBMET00328 | DBMET00328 | |
| 0.009 | 0.202 | 0.105 | Cathepsin K inhibitor | 0.105 0.005 DBMET00328 | DBMET00328 | |
| 0.009 | 0.204 | 0.041 | Retinoid X gamma receptor antagonist | 0.041 0.004 DBMET00484 | DBMET00484 | |
| 0.011 | 0.213 | 0.032 | Growth factor receptor-bound protein 2 antagonist | 0.032 0.031 DBMET00484 | DBMET00484 | |
| 0.117 | 0.32 | 0.302 | Peptidyltransferase inhibitor | 0.302 0.024 DBMET00484 | DBMET00484 | |
| 0.001 | 0.208 | 0.021 | Antibiotic Macrolide-like | 0.021 0.006 DBMET00328 | DBMET00328 | |
| 0.007 | 0.217 | 0.055 | Prostaglandin D2 agonist | 0.055 0.006 DBMET00484 | DBMET00484 | |
| 0.027 | 0.238 | 0.055 | Factor III inhibitor | 0.055 0.024 DBMET00484 | DBMET00484 | |
| 0.017 | 0.232 | 0.123 | Carbonic anhydrase V inhibitor | 0.123 0.021 DBMET00484 | DBMET00484 | |
| 0.028 | 0.245 | 0.113 | Protease 3C (Human rhinovirus) inhibitor | 0.113 0.011 DBMET00328 0.087 0.022 DBMET00484 | DBMET00328 | |
| 0.003 | 0.231 | 0.011 | Retinoic acid receptor gamma antagonist | 0.011 0.009 DBMET00484 | DBMET00484 | |
| 0.008 | 0.238 | 0.032 | Nicotinic acid receptor 2 agonist | 0.032 0.031 DBMET00484 | DBMET00484 | |
| 0.043 | 0.273 | 0.16 | Proteasome inhibitor | 0.16 0.041 DBMET00328 0.127 0.06 DBMET00484 | DBMET00328 | |
| 0.004 | 0.242 | 0.027 | Retinoic acid alpha receptor antagonist | 0.027 0.008 DBMET00484 | DBMET00484 | |
| 0.015 | 0.262 | 0.188 | Plasmin inhibitor | 0.188 0.007 DBMET00328 | DBMET00328 | |
| 0.017 | 0.266 | 0.032 | HCV polyprotein inhibitor | 0.032 0.031 DBMET00484 | DBMET00484 | |
| 0.063 | 0.329 | 0.285 | Hepatoprotectant | 0.285 0.034 DBMET00484 | DBMET00484 | |
| 0.018 | 0.285 | 0.033 | Calcium-independent phospholipase A2 inhibitor | 0.033 0.029 DBMET00484 | DBMET00484 | |
| 0.043 | 0.312 | 0.103 | Thioredoxin reductase inhibitor | 0.103 0.026 DBMET00328 0.078 0.068 DBMET00484 | DBMET00328 | |
| 0.002 | 0.275 | 0.011 | Retinoic acid beta receptor antagonist | 0.011 0.009 DBMET00484 | DBMET00484 | |
| 0.012 | 0.286 | 0.096 | Plasminogen activator inhibitor | 0.096 0.018 DBMET00328 | DBMET00328 | |
| 0.066 | 0.34 | 0.279 | Calpain inhibitor | 0.279 0.042 DBMET00328 0.211 0.103 DBMET00484 | DBMET00328 | |
| 0.044 | 0.324 | 0.321 | Angiogenesis stimulant | 0.321 0.042 DBMET00484 | DBMET00484 | |
| 0.004 | 0.285 | 0.024 | Retinoic acid receptor antagonist | 0.024 0.008 DBMET00484 | DBMET00484 | |
| 0.028 | 0.331 | 0.077 | Adenine nucleotide translocase inhibitor | 0.077 0.01 DBMET00484 | DBMET00484 | |
| 0.005 | 0.309 | 0.03 | Integrin alphaVbeta3 antagonist | 0.03 0.008 DBMET00484 | DBMET00484 | |
| 0.002 | 0.307 | 0.015 | N-Acetylated alpha-linked acidic dipeptidase inhibitor | 0.015 0.009 DBMET00484 | DBMET00484 | |
| 0.04 | 0.346 | 0.198 | ABCA1 expression enhancer | 0.198 0.009 DBMET00328 0.188 0.011 DBMET00484 | DBMET00328 | |
| 0.021 | 0.33 | 0.174 | GABA aminotransferase inhibitor | 0.102 0.025 DBMET00328 0.174 0.005 DBMET00484 | DBMET00484 | |
| 0.002 | 0.311 | 0.015 | Immunosuppressant Cyclosporine-like | 0.015 0.005 DBMET00328 0.012 0.008 DBMET00484 | DBMET00328 | |
| 0.032 | 0.346 | 0.229 | Protein-tyrosine phosphatase inhibitor | 0.229 0.037 DBMET00484 | DBMET00484 | |
| 0.027 | 0.343 | 0.083 | Trypsin inhibitor | 0.083 0.025 DBMET00328 | DBMET00328 | |
| 0.005 | 0.325 | 0.029 | Trypsin I inhibitor | 0.029 0.027 DBMET00328 | DBMET00328 | |
| 0.009 | 0.331 | 0.038 | Caspase 6 inhibitor | 0.038 0.009 DBMET00328 0.032 0.017 DBMET00484 | DBMET00328 | |
| 0.006 | 0.334 | 0.053 | Caspase 2 inhibitor | 0.053 0.011 DBMET00328 0.05 0.012 DBMET00484 | DBMET00328 | |
| 0.01 | 0.342 | 0.044 | Endothelin-converting enzyme inhibitor | 0.044 0.035 DBMET00484 | DBMET00484 | |
| 0.069 | 0.415 | 0.406 | Hypoglycemic | 0.406 0.027 DBMET00484 | DBMET00484 | |
| 0.003 | 0.352 | 0.036 | Prostacyclin agonist | 0.036 0.005 DBMET00484 | DBMET00484 | |
| 0.011 | 0.367 | 0.182 | Monophenol monooxygenase inhibitor | 0.182 0.037 DBMET00484 | DBMET00484 | |
| 0.008 | 0.376 | 0.16 | HIV-1 integrase (Strand Transfer) inhibitor | 0.16 0.012 DBMET00484 | DBMET00484 | |
| 0.027 | 0.398 | 0.216 | Microtubule formation inhibitor | 0.167 0.03 DBMET00328 0.216 0.016 DBMET00484 | DBMET00484 | |
| 0.016 | 0.389 | 0.101 | Thrombin inhibitor | 0.101 0.025 DBMET00328 | DBMET00328 | |
| 0.005 | 0.384 | 0.026 | Integrin beta5 antagonist | 0.026 0.01 DBMET00484 | DBMET00484 | |
| 0.009 | 0.39 | 0.086 | Selectin antagonist | 0.086 0.034 DBMET00484 | DBMET00484 | |
| 0.006 | 0.388 | 0.031 | Retinoic acid gamma receptor agonist | 0.031 0.006 DBMET00484 | DBMET00484 | |
| 0.006 | 0.388 | 0.027 | Retinoic acid beta receptor agonist | 0.027 0.007 DBMET00484 | DBMET00484 | |
| 0.01 | 0.398 | 0.412 | Catalase inhibitor | 0.244 0.009 DBMET00328 0.412 0.003 DBMET00484 | DBMET00484 | |
| 0.008 | 0.398 | 0.121 | HIV-1 integrase (3'-Processing) inhibitor | 0.121 0.019 DBMET00484 | DBMET00484 | |
| 0.004 | 0.397 | 0.107 | GP IIb/IIIa receptor antagonist | 0.107 0.016 DBMET00484 | DBMET00484 | |
| 0.006 | 0.402 | 0.035 | Trypsin II inhibitor | 0.035 0.016 DBMET00328 | DBMET00328 | |
| 0.014 | 0.411 | 0.053 | Human rhinovirus A protease inhibitor | 0.053 0.04 DBMET00328 | DBMET00328 | |
| 0.049 | 0.447 | 0.287 | 3C-like protease (Human coronavirus) inhibitor | 0.287 0.014 DBMET00328 0.178 0.067 DBMET00484 | DBMET00328 | |
| 0.028 | 0.438 | 0.08 | Falcipain inhibitor | 0.08 0.074 DBMET00328 | DBMET00328 | |
| 0.018 | 0.432 | 0.267 | Mucolytic | 0.134 0.043 DBMET00328 0.267 0.005 DBMET00484 | DBMET00484 | |
| 0.012 | 0.441 | 0.114 | Carbonic anhydrase VA inhibitor | 0.114 0.02 DBMET00484 | DBMET00484 | |
| 0.008 | 0.438 | 0.073 | Glutamate (mGluR3) agonist | 0.037 0.014 DBMET00328 0.073 0.003 DBMET00484 | DBMET00484 | |
| 0.091 | 0.524 | 0.425 | Interleukin 2 agonist | 0.425 0.021 DBMET00484 | DBMET00484 | |
| 0.011 | 0.448 | 0.128 | Leukotriene synthesis inhibitor | 0.128 0.014 DBMET00484 | DBMET00484 | |
| 0.005 | 0.447 | 0.062 | Cathepsin L inhibitor | 0.062 0.036 DBMET00328 | DBMET00328 | |
| 0.004 | 0.448 | 0.033 | Vitronectin receptor antagonist | 0.033 0.009 DBMET00484 | DBMET00484 | |
| 0.003 | 0.45 | 0.02 | Corticosteroid-like | 0.02 0.017 DBMET00484 | DBMET00484 | |
| 0.003 | 0.452 | 0.022 | Integrin beta3 antagonist | 0.022 0.012 DBMET00484 | DBMET00484 | |
| 0.01 | 0.46 | 0.107 | Lipase inhibitor | 0.107 0.024 DBMET00328 | DBMET00328 | |
| 0.021 | 0.477 | 0.118 | DNA helicase inhibitor | 0.118 0.004 DBMET00484 | DBMET00484 | |
| 0.008 | 0.468 | 0.063 | Retinoic acid alpha receptor agonist | 0.063 0.008 DBMET00484 | DBMET00484 | |
| 0.007 | 0.475 | 0.082 | Glutamate (mGluR1) agonist | 0.028 0.012 DBMET00328 0.082 0.004 DBMET00484 | DBMET00484 | |
| 0.009 | 0.485 | 0.093 | CDC25B inhibitor | 0.093 0.019 DBMET00328 0.09 0.021 DBMET00484 | DBMET00328 | |
| 0.011 | 0.488 | 0.275 | Expectorant | 0.105 0.063 DBMET00328 0.275 0.01 DBMET00484 | DBMET00484 | |
| 0.006 | 0.484 | 0.025 | NMDA 2D receptor antagonist | 0.025 0.022 DBMET00484 | DBMET00484 | |
| 0.04 | 0.519 | 0.259 | DNA damaging | 0.259 0.076 DBMET00484 | DBMET00484 | |
| 0.021 | 0.503 | 0.854 | Alpha-N-acetylglucosaminidase inhibitor | 0.816 0.002 DBMET00328 0.854 0.002 DBMET00484 | DBMET00484 | |
| 0.008 | 0.492 | 0.091 | Maillard reaction inhibitor | 0.091 0.02 DBMET00484 | DBMET00484 | |
| 0.006 | 0.49 | 0.153 | NMDA receptor glycine site agonist | 0.069 0.037 DBMET00328 0.153 0.004 DBMET00484 | DBMET00484 | |
| 0.02 | 0.508 | 0.217 | Pyruvate kinase inhibitor | 0.192 0.086 DBMET00328 0.217 0.073 DBMET00484 | DBMET00484 | |
| 0.007 | 0.502 | 0.382 | Carbamoyl phosphate synthetase inhibitor | 0.162 0.01 DBMET00328 0.382 0.003 DBMET00484 | DBMET00484 | |
| 0.001 | 0.499 | 0.039 | Glutamate (mGluR6) agonist | 0.012 0.008 DBMET00328 0.039 0.003 DBMET00484 | DBMET00484 | |
| 0.003 | 0.501 | 0.077 | VLA-4 antagonist | 0.077 0.008 DBMET00484 | DBMET00484 | |
| 0.01 | 0.512 | 0.034 | Cholecystokinin B agonist | 0.034 0.031 DBMET00484 | DBMET00484 | |
| 0.003 | 0.506 | 0.023 | Kainate receptor 5 antagonist | 0.023 0.013 DBMET00484 | DBMET00484 | |
| 0.003 | 0.519 | 0.074 | Retinoid X beta receptor agonist | 0.074 0.004 DBMET00484 | DBMET00484 | |
| 0.026 | 0.545 | 0.078 | Lipocortins synthesis agonist | 0.078 0.015 DBMET00484 | DBMET00484 | |
| 0.013 | 0.532 | 0.2 | Falcipain 3 inhibitor | 0.2 0.018 DBMET00328 0.132 0.046 DBMET00484 | DBMET00328 | |
| 0.005 | 0.526 | 0.194 | Peroxisome proliferator-activated receptor gamma agonist | 0.194 0.007 DBMET00484 | DBMET00484 | |
| 0.009 | 0.532 | 0.123 | CDC25A inhibitor | 0.123 0.018 DBMET00484 | DBMET00484 | |
| 0.034 | 0.562 | 0.087 | Hematopoietic | 0.087 0.056 DBMET00484 | DBMET00484 | |
| 0.01 | 0.539 | 0.109 | Glutamate (mGluR8) agonist | 0.058 0.008 DBMET00328 0.109 0.003 DBMET00484 | DBMET00484 | |
| 0.039 | 0.571 | 0.157 | Folate antagonist | 0.157 0.02 DBMET00484 | DBMET00484 | |
| 0.003 | 0.536 | 0.23 | Ornithine carbamoyltransferase inhibitor | 0.17 0.008 DBMET00328 0.23 0.006 DBMET00484 | DBMET00484 | |
| 0.015 | 0.551 | 0.128 | Neurotrophic factor | 0.128 0.083 DBMET00328 | DBMET00328 | |
| 0.006 | 0.548 | 0.188 | Protein-tyrosine phosphatase 1B inhibitor | 0.188 0.032 DBMET00484 | DBMET00484 | |
| 0.009 | 0.552 | 0.205 | NMDA receptor agonist | 0.062 0.044 DBMET00328 0.205 0.004 DBMET00484 | DBMET00484 | |
| 0.017 | 0.569 | 0.348 | Immunostimulant | 0.25 0.096 DBMET00328 0.348 0.065 DBMET00484 | DBMET00484 | |
| 0.003 | 0.559 | 0.082 | Retinoid X gamma receptor agonist | 0.082 0.004 DBMET00484 | DBMET00484 | |
| 0.003 | 0.56 | 0.034 | Integrin beta7 antagonist | 0.034 0.009 DBMET00484 | DBMET00484 | |
| 0.004 | 0.565 | 0.074 | Prostacyclin antagonist | 0.074 0.006 DBMET00484 | DBMET00484 | |
| 0.009 | 0.571 | 0.109 | M17 leucyl aminopeptidase inhibitor | 0.109 0.09 DBMET00484 | DBMET00484 | |
| 0.012 | 0.577 | 0.151 | Cathepsin G inhibitor | 0.122 0.027 DBMET00328 0.151 0.021 DBMET00484 | DBMET00484 | |
| 0.016 | 0.586 | 0.233 | Glycine receptor agonist | 0.117 0.014 DBMET00328 0.233 0.003 DBMET00484 | DBMET00484 | |
| 0.019 | 0.591 | 0.556 | Triose-phosphate isomerase inhibitor | 0.423 0.003 DBMET00328 0.556 0.002 DBMET00484 | DBMET00484 | |
| 0.018 | 0.59 | 0.195 | Glutamate (mGluR6) antagonist | 0.1 0.01 DBMET00328 0.195 0.003 DBMET00484 | DBMET00484 | |
| 0.005 | 0.578 | 0.026 | Caspase 8 inhibitor | 0.021 0.011 DBMET00328 0.026 0.007 DBMET00484 | DBMET00484 | |
| 0.004 | 0.585 | 0.089 | Peroxisome proliferator-activated receptor delta antagonist | 0.089 0.006 DBMET00484 | DBMET00484 | |
| 0.003 | 0.585 | 0.051 | Free fatty acid receptor 1 agonist | 0.051 0.005 DBMET00484 | DBMET00484 | |
| 0.013 | 0.598 | 0.168 | Caspase 3 inhibitor | 0.148 0.029 DBMET00328 0.168 0.018 DBMET00484 | DBMET00484 | |
| 0.012 | 0.598 | 0.177 | Ornithine decarboxylase inhibitor | 0.13 0.019 DBMET00328 0.177 0.006 DBMET00484 | DBMET00484 | |
| 0.003 | 0.597 | 0.04 | Cathepsin L1 inhibitor | 0.04 0.027 DBMET00328 | DBMET00328 | |
| 0.071 | 0.668 | 0.123 | CC chemokine 6 receptor antagonist | 0.123 0.099 DBMET00484 | DBMET00484 | |
| 0.004 | 0.601 | 0.024 | Kainate receptor 4 antagonist | 0.024 0.018 DBMET00484 | DBMET00484 | |
| 0.005 | 0.602 | 0.066 | Macrophage elastase inhibitor | 0.066 0.016 DBMET00484 | DBMET00484 | |
| 0.021 | 0.627 | 0.233 | Nitric oxide antagonist | 0.157 0.09 DBMET00328 0.233 0.057 DBMET00484 | DBMET00484 | |
| 0.003 | 0.612 | 0.019 | Kainate receptor 3 antagonist | 0.019 0.01 DBMET00484 | DBMET00484 | |
| 0.02 | 0.632 | 0.197 | Thiol protease inhibitor | 0.197 0.04 DBMET00328 0.15 0.068 DBMET00484 | DBMET00328 | |
| 0.02 | 0.632 | 0.17 | Farnesoid X receptor antagonist | 0.17 0.035 DBMET00484 | DBMET00484 | |
| 0.006 | 0.62 | 0.082 | Plasminogen activator inhibitor antagonist | 0.082 0.014 DBMET00484 | DBMET00484 | |
| 0.004 | 0.623 | 0.036 | AMPA receptor agonist | 0.036 0.023 DBMET00484 | DBMET00484 | |
| 0.017 | 0.638 | 0.149 | Thioredoxin inhibitor | 0.149 0.017 DBMET00484 | DBMET00484 | |
| 0.006 | 0.631 | 0.027 | Baculoviral IAP repeat-containing protein 4 inhibitor | 0.027 0.02 DBMET00484 | DBMET00484 | |
| 0.005 | 0.633 | 0.105 | Mannosidase inhibitor | 0.096 0.006 DBMET00328 0.105 0.005 DBMET00484 | DBMET00484 | |
| 0.011 | 0.643 | 0.685 | GABA C receptor agonist | 0.365 0.006 DBMET00328 0.685 0.002 DBMET00484 | DBMET00484 | |
| 0.049 | 0.683 | 0.169 | Catenin beta inhibitor | 0.169 0.068 DBMET00484 | DBMET00484 | |
| 0.007 | 0.644 | 0.052 | VCAM-1 antagonist | 0.052 0.008 DBMET00484 | DBMET00484 | |
| 0.007 | 0.644 | 0.052 | VCAM antagonist | 0.052 0.008 DBMET00484 | DBMET00484 | |
| 0.003 | 0.641 | 0.085 | Integrin alpha4 antagonist | 0.085 0.007 DBMET00484 | DBMET00484 | |
| 0.004 | 0.643 | 0.117 | Na+ K+ transporting ATPase inhibitor | 0.116 0.019 DBMET00328 0.117 0.018 DBMET00484 | DBMET00484 | |
| 0.041 | 0.682 | 0.271 | Apoptosis agonist | 0.271 0.194 DBMET00484 | DBMET00484 | |
| 0.005 | 0.649 | 0.074 | Metalloproteinase-2 inhibitor | 0.074 0.059 DBMET00484 | DBMET00484 | |
| 0.004 | 0.649 | 0.057 | Prolyl endopeptidase inhibitor | 0.057 0.027 DBMET00328 0.054 0.031 DBMET00484 | DBMET00328 | |
| 0.005 | 0.652 | 0.605 | Glutamate decarboxylase inhibitor | 0.244 0.005 DBMET00328 0.605 0.002 DBMET00484 | DBMET00484 | |
| 0.004 | 0.652 | 0.04 | AMPA 2 receptor antagonist | 0.04 0.014 DBMET00484 | DBMET00484 | |
| 0.002 | 0.651 | 0.027 | Antibiotic Anthracycline-like | 0.019 0.012 DBMET00328 0.027 0.004 DBMET00484 | DBMET00484 | |
| 0.005 | 0.655 | 0.055 | Integrin alpha5beta1 antagonist | 0.055 0.015 DBMET00484 | DBMET00484 | |
| 0.004 | 0.656 | 0.045 | Calcitonin receptor agonist | 0.031 0.026 DBMET00328 0.045 0.018 DBMET00484 | DBMET00484 | |
| 0.016 | 0.673 | 0.43 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.211 0.014 DBMET00328 0.43 0.003 DBMET00484 | DBMET00484 | |
| 0.004 | 0.663 | 0.178 | Prostaglandin EP2 antagonist | 0.178 0.008 DBMET00484 | DBMET00484 | |
| 0.043 | 0.703 | 0.442 | Apoptosis antagonist | 0.358 0.052 DBMET00328 0.442 0.029 DBMET00484 | DBMET00484 | |
| 0.004 | 0.665 | 0.149 | Integrin antagonist | 0.149 0.01 DBMET00484 | DBMET00484 | |
| 0.008 | 0.67 | 0.067 | Potassium channel intermediate-conductance Ca-activated blocker | 0.067 0.03 DBMET00328 0.064 0.035 DBMET00484 | DBMET00328 | |
| 0.002 | 0.666 | 0.031 | Neuraminidase (Influenza B) inhibitor | 0.022 0.011 DBMET00328 0.031 0.004 DBMET00484 | DBMET00484 | |
| 0.001 | 0.666 | 0.055 | Carbonic anhydrase VIII inhibitor | 0.029 0.004 DBMET00328 0.055 0.002 DBMET00484 | DBMET00484 | |
| 0.001 | 0.666 | 0.055 | Carbonic anhydrase X inhibitor | 0.029 0.004 DBMET00328 0.055 0.002 DBMET00484 | DBMET00484 | |
| 0.002 | 0.668 | 0.113 | Glutamate (mGluR1a) agonist | 0.041 0.005 DBMET00328 0.113 0.003 DBMET00484 | DBMET00484 | |
| 0.003 | 0.672 | 0.069 | Squalene synthetase inhibitor | 0.069 0.01 DBMET00484 | DBMET00484 | |
| 0.014 | 0.685 | 0.294 | Electrolyte absorption antagonist | 0.16 0.016 DBMET00328 0.294 0.004 DBMET00484 | DBMET00484 | |
| 0.01 | 0.681 | 0.134 | Anticoagulant | 0.134 0.096 DBMET00484 | DBMET00484 | |
| 0.002 | 0.675 | 0.073 | Peroxisome proliferator-activated receptor alpha agonist | 0.073 0.02 DBMET00484 | DBMET00484 | |
| 0.003 | 0.677 | 0.061 | Complement C3a chemotactic receptor antagonist | 0.061 0.021 DBMET00484 | DBMET00484 | |
| 0.01 | 0.686 | 0.057 | Carnitine palmitoyltransferase 1B inhibitor | 0.057 0.02 DBMET00484 | DBMET00484 | |
| 0.01 | 0.689 | 0.432 | UDP-glucose 4-epimerase inhibitor | 0.432 0.004 DBMET00328 0.412 0.005 DBMET00484 | DBMET00328 | |
| 0.005 | 0.684 | 0.046 | Cholesterol esterase inhibitor | 0.046 0.036 DBMET00484 | DBMET00484 | |
| 0.013 | 0.696 | 0.056 | Integrin alpha1beta1 antagonist | 0.056 0.005 DBMET00484 | DBMET00484 | |
| 0.005 | 0.689 | 0.368 | Histidine decarboxylase inhibitor | 0.156 0.019 DBMET00328 0.368 0.004 DBMET00484 | DBMET00484 | |
| 0.016 | 0.7 | 0.079 | Vanilloid agonist | 0.079 0.073 DBMET00484 | DBMET00484 | |
| 0.005 | 0.696 | 0.125 | Membrane dipeptidase inhibitor | 0.05 0.015 DBMET00328 0.125 0.003 DBMET00484 | DBMET00484 | |
| 0.019 | 0.712 | 0.17 | DNA polymerase I inhibitor | 0.17 0.039 DBMET00484 | DBMET00484 | |
| 0.005 | 0.698 | 0.117 | Alpha-mannosidase inhibitor | 0.11 0.005 DBMET00328 0.117 0.005 DBMET00484 | DBMET00484 | |
| 0.012 | 0.706 | 0.246 | Bone formation stimulant | 0.246 0.025 DBMET00484 | DBMET00484 | |
| 0.001 | 0.695 | 0.063 | Kynurenine 3 monooxygenase inhibitor | 0.063 0.005 DBMET00484 | DBMET00484 | |
| 0.019 | 0.714 | 0.153 | Toll-Like receptor 4 antagonist | 0.153 0.019 DBMET00484 | DBMET00484 | |
| 0.019 | 0.723 | 0.243 | Hypoxia-inducible factor 1 alpha inhibitor | 0.206 0.145 DBMET00328 0.243 0.107 DBMET00484 | DBMET00484 | |
| 0.004 | 0.71 | 0.044 | Prostaglandin E2 antagonist | 0.044 0.043 DBMET00484 | DBMET00484 | |
| 0.012 | 0.718 | 0.154 | Xanthine oxidase inhibitor | 0.086 0.079 DBMET00328 0.154 0.033 DBMET00484 | DBMET00484 | |
| 0.009 | 0.723 | 0.272 | Insulin sensitizer | 0.154 0.128 DBMET00328 0.272 0.024 DBMET00484 | DBMET00484 | |
| 0.003 | 0.717 | 0.244 | Acyl-CoA dehydrogenase inhibitor | 0.172 0.007 DBMET00328 0.244 0.003 DBMET00484 | DBMET00484 | |
| 0.008 | 0.726 | 0.207 | Uric acid excretion stimulant | 0.207 0.012 DBMET00484 | DBMET00484 | |
| 0.004 | 0.722 | 0.028 | Methylmalonyl-CoA mutase inhibitor | 0.027 0.003 DBMET00328 0.028 0.003 DBMET00484 | DBMET00484 | |
| 0.007 | 0.728 | 0.04 | Erythropoietin receptor agonist | 0.04 0.029 DBMET00484 | DBMET00484 | |
| 0.04 | 0.761 | 0.39 | Lipocortins synthesis antagonist | 0.39 0.009 DBMET00484 | DBMET00484 | |
| 0.011 | 0.733 | 0.407 | Glutamate dehydrogenase inhibitor | 0.17 0.013 DBMET00328 0.407 0.004 DBMET00484 | DBMET00484 | |
| 0.001 | 0.725 | 0.06 | Lysine carboxypeptidase inhibitor | 0.06 0.006 DBMET00484 | DBMET00484 | |
| 0.025 | 0.749 | 0.386 | Vasodilator, coronary | 0.27 0.114 DBMET00328 0.386 0.04 DBMET00484 | DBMET00484 | |
| 0.014 | 0.74 | 0.189 | Carbonic anhydrase III inhibitor | 0.096 0.067 DBMET00328 0.189 0.018 DBMET00484 | DBMET00484 | |
| 0.007 | 0.733 | 0.165 | Glucose-6-phosphate isomerase inhibitor | 0.144 0.003 DBMET00328 0.165 0.002 DBMET00484 | DBMET00484 | |
| 0.001 | 0.728 | 0.348 | Fumarate hydratase inhibitor | 0.074 0.008 DBMET00328 0.348 0.002 DBMET00484 | DBMET00484 | |
| 0.002 | 0.729 | 0.08 | GABA uptake inhibitor | 0.068 0.008 DBMET00328 0.08 0.005 DBMET00484 | DBMET00484 | |
| 0.004 | 0.733 | 0.077 | Sphingosine 1-phosphate receptor 3 antagonist | 0.077 0.019 DBMET00484 | DBMET00484 | |
| 0.012 | 0.747 | 0.227 | DOPA decarboxylase inhibitor | 0.162 0.016 DBMET00328 0.227 0.004 DBMET00484 | DBMET00484 | |
| 0.006 | 0.744 | 0.127 | Calcium antagonist | 0.084 0.06 DBMET00328 0.127 0.031 DBMET00484 | DBMET00484 | |
| 0.002 | 0.74 | 0.053 | Carbonic anhydrase inhibitor | 0.053 0.052 DBMET00484 | DBMET00484 | |
| 0.003 | 0.741 | 0.026 | Leukotriene D4 antagonist | 0.026 0.019 DBMET00484 | DBMET00484 | |
| 0.011 | 0.751 | 0.256 | Aminopeptidase B inhibitor | 0.212 0.019 DBMET00328 0.256 0.012 DBMET00484 | DBMET00484 | |
| 0.012 | 0.753 | 0.547 | Succinate dehydrogenase inhibitor | 0.445 0.004 DBMET00328 0.547 0.003 DBMET00484 | DBMET00484 | |
| 0.012 | 0.753 | 0.165 | Carbonic anhydrase VI inhibitor | 0.165 0.018 DBMET00484 | DBMET00484 | |
| 0.006 | 0.748 | 0.103 | Sphingosine 1-phosphate receptor 5 agonist | 0.103 0.008 DBMET00484 | DBMET00484 | |
| 0.035 | 0.778 | 0.419 | Sodium/bile acid cotransporter inhibitor | 0.419 0.012 DBMET00484 | DBMET00484 | |
| 0.012 | 0.755 | 0.046 | Glucagon-like peptide 1 receptor antagonist | 0.046 0.017 DBMET00484 | DBMET00484 | |
| 0.002 | 0.755 | 0.029 | Lysophosphatidic acid 1 receptor antagonist | 0.029 0.007 DBMET00484 | DBMET00484 | |
| 0.001 | 0.754 | 0.034 | NMDA receptor glycine site antagonist | 0.034 0.011 DBMET00484 | DBMET00484 | |
| 0.002 | 0.759 | 0.945 | Alcohol oxidase inhibitor | 0.853 0.002 DBMET00328 0.945 0.001 DBMET00484 | DBMET00484 | |
| 0.001 | 0.76 | 0.094 | Arginase inhibitor | 0.037 0.025 DBMET00328 0.094 0.004 DBMET00484 | DBMET00484 | |
| 0.005 | 0.766 | 0.116 | Kainate receptor agonist | 0.058 0.008 DBMET00328 0.116 0.002 DBMET00484 | DBMET00484 | |
| 0.009 | 0.77 | 0.298 | Antioxidant | 0.298 0.062 DBMET00484 | DBMET00484 | |
| 0.001 | 0.763 | 0.041 | Retinoid X beta receptor antagonist | 0.023 0.009 DBMET00328 0.041 0.003 DBMET00484 | DBMET00484 | |
| 0.003 | 0.765 | 0.336 | Biliverdin reductase inhibitor | 0.162 0.008 DBMET00328 0.336 0.003 DBMET00484 | DBMET00484 | |
| 0.003 | 0.767 | 0.03 | Integrin alphaVbeta1 antagonist | 0.03 0.006 DBMET00484 | DBMET00484 | |
| 0.005 | 0.77 | 0.059 | Retinoid X alpha receptor antagonist | 0.036 0.021 DBMET00328 0.059 0.004 DBMET00484 | DBMET00484 | |
| 0.006 | 0.77 | 0.072 | Calcium channel L-type blocker | 0.072 0.049 DBMET00484 | DBMET00484 | |
| 0.02 | 0.785 | 0.383 | Adenylate kinase inhibitor | 0.356 0.004 DBMET00328 0.383 0.004 DBMET00484 | DBMET00484 | |
| 0.003 | 0.768 | 0.023 | Leukotriene B4 receptor 2 antagonist | 0.023 0.014 DBMET00484 | DBMET00484 | |
| 0.01 | 0.777 | 0.246 | Vasodilator | 0.246 0.071 DBMET00484 | DBMET00484 | |
| 0.004 | 0.771 | 0.075 | Glucagon-like peptide 1 agonist | 0.075 0.038 DBMET00484 | DBMET00484 | |
| 0.009 | 0.779 | 0.067 | CD45 antagonist | 0.067 0.017 DBMET00484 | DBMET00484 | |
| 0.002 | 0.773 | 0.324 | Phosphofructokinase-1 inhibitor | 0.273 0.006 DBMET00328 0.324 0.005 DBMET00484 | DBMET00484 | |
| 0.005 | 0.777 | 0.136 | 5-Lipoxygenase inhibitor | 0.136 0.043 DBMET00484 | DBMET00484 | |
| 0.002 | 0.776 | 0.311 | Argininosuccinate synthase inhibitor | 0.278 0.004 DBMET00328 0.311 0.004 DBMET00484 | DBMET00484 | |
| 0 | 0.775 | 0.036 | Lysophosphatidic acid receptor 3 agonist | 0.02 0.005 DBMET00328 0.036 0.003 DBMET00484 | DBMET00484 | |
| 0 | 0.775 | 0.025 | Aminopeptidase A inhibitor | 0.025 0.008 DBMET00484 | DBMET00484 | |
| 0.005 | 0.782 | 0.068 | Retinoid X receptor antagonist | 0.04 0.024 DBMET00328 0.068 0.004 DBMET00484 | DBMET00484 | |
| 0.011 | 0.788 | 0.439 | Antithrombotic | 0.301 0.087 DBMET00328 0.439 0.04 DBMET00484 | DBMET00484 | |
| 0.004 | 0.785 | 0.232 | Prostaglandin antagonist | 0.232 0.005 DBMET00484 | DBMET00484 | |
| 0.003 | 0.785 | 0.053 | Matrix metalloproteinase (membrane-type) inhibitor | 0.053 0.041 DBMET00484 | DBMET00484 | |
| 0.015 | 0.799 | 0.612 | Cholesterol antagonist | 0.318 0.08 DBMET00328 0.612 0.017 DBMET00484 | DBMET00484 | |
| 0.004 | 0.788 | 0.228 | Phospholipase A2 inhibitor | 0.139 0.087 DBMET00328 0.228 0.03 DBMET00484 | DBMET00484 | |
| 0.005 | 0.789 | 0.145 | Glycine receptor antagonist | 0.117 0.02 DBMET00328 0.145 0.009 DBMET00484 | DBMET00484 | |
| 0.001 | 0.787 | 0.076 | Kainate receptor antagonist | 0.076 0.011 DBMET00484 | DBMET00484 | |
| 0.009 | 0.795 | 0.149 | Glutathione S-transferase inhibitor | 0.087 0.052 DBMET00328 0.149 0.012 DBMET00484 | DBMET00484 | |
| 0.02 | 0.809 | 0.148 | DNA repair enzyme inhibitor | 0.107 0.103 DBMET00328 0.148 0.033 DBMET00484 | DBMET00484 | |
| 0.005 | 0.794 | 0.479 | Anesthetic general | 0.247 0.051 DBMET00328 0.479 0.009 DBMET00484 | DBMET00484 | |
| 0.001 | 0.791 | 0.082 | Antimetabolite | 0.046 0.034 DBMET00328 0.082 0.019 DBMET00484 | DBMET00484 | |
| 0 | 0.79 | 0.034 | Prostaglandin EP4 agonist | 0.034 0.006 DBMET00484 | DBMET00484 | |
| 0.003 | 0.794 | 0.075 | Thromboxane synthase inhibitor | 0.075 0.014 DBMET00484 | DBMET00484 | |
| 0.003 | 0.795 | 0.099 | Lysophosphatidic acid 3 receptor antagonist | 0.061 0.021 DBMET00328 0.099 0.005 DBMET00484 | DBMET00484 | |
| 0.003 | 0.796 | 0.297 | Aconitate hydratase inhibitor | 0.106 0.007 DBMET00328 0.297 0.002 DBMET00484 | DBMET00484 | |
| 0.002 | 0.796 | 0.041 | Leukotriene B4 receptor 1 antagonist | 0.041 0.011 DBMET00484 | DBMET00484 | |
| 0.002 | 0.799 | 0.065 | Neutrophil collagenase inhibitor | 0.065 0.045 DBMET00484 | DBMET00484 | |
| 0.003 | 0.8 | 0.063 | Dihydroorotase inhibitor | 0.042 0.036 DBMET00328 0.063 0.014 DBMET00484 | DBMET00484 | |
| 0.011 | 0.809 | 0.19 | P-glycoprotein inhibitor | 0.19 0.071 DBMET00484 | DBMET00484 | |
| 0.001 | 0.8 | 0.023 | Methionyl aminopeptidase 2 inhibitor | 0.023 0.02 DBMET00484 | DBMET00484 | |
| 0 | 0.8 | 0.021 | Carbonic anhydrase XI inhibitor | 0.013 0.009 DBMET00328 0.021 0.004 DBMET00484 | DBMET00484 | |
| 0.004 | 0.804 | 0.067 | Dopamine beta hydroxylase inhibitor | 0.055 0.021 DBMET00328 0.067 0.009 DBMET00484 | DBMET00484 | |
| 0.016 | 0.818 | 0.086 | Interleukin 5 antagonist | 0.086 0.061 DBMET00328 | DBMET00328 | |
| 0.003 | 0.805 | 0.044 | Carboxypeptidase B inhibitor | 0.044 0.01 DBMET00484 | DBMET00484 | |
| 0.002 | 0.808 | 0.094 | Toll-Like receptor 2 agonist | 0.036 0.034 DBMET00328 0.094 0.015 DBMET00484 | DBMET00484 | |
| 0.002 | 0.808 | 0.084 | Acetylcholine M5 receptor agonist | 0.081 0.033 DBMET00328 0.084 0.031 DBMET00484 | DBMET00484 | |
| 0.004 | 0.81 | 0.092 | Peroxisome proliferator-activated receptor gamma antagonist | 0.092 0.021 DBMET00484 | DBMET00484 | |
| 0.004 | 0.811 | 0.126 | Glutamate (mGluR7) antagonist | 0.099 0.011 DBMET00328 0.126 0.004 DBMET00484 | DBMET00484 | |
| 0.002 | 0.809 | 0.054 | Lysophosphatidic acid receptor 1 agonist | 0.031 0.01 DBMET00328 0.054 0.004 DBMET00484 | DBMET00484 | |
| 0.004 | 0.812 | 0.081 | Glutamate (mGluR group III) agonist | 0.081 0.013 DBMET00484 | DBMET00484 | |
| 0.001 | 0.813 | 0.059 | Phosphoglycerate kinase inhibitor | 0.036 0.023 DBMET00328 0.059 0.011 DBMET00484 | DBMET00484 | |
| 0.01 | 0.823 | 0.178 | Sphingosine 1-phosphate receptor 4 antagonist | 0.131 0.055 DBMET00328 0.178 0.015 DBMET00484 | DBMET00484 | |
| 0.001 | 0.814 | 0.025 | Nicotinic acid receptor 1 antagonist | 0.025 0.005 DBMET00484 | DBMET00484 | |
| 0.005 | 0.819 | 0.083 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.06 0.007 DBMET00328 0.083 0.004 DBMET00484 | DBMET00484 | |
| 0 | 0.814 | 0.03 | Peroxisome proliferator-activated receptor alpha antagonist | 0.03 0.012 DBMET00484 | DBMET00484 | |
| 0 | 0.816 | 0.011 | Carboxypeptidase B2 inhibitor | 0.011 0.008 DBMET00484 | DBMET00484 | |
| 0.002 | 0.818 | 0.02 | CXC chemokine 5 receptor antagonist | 0.02 0.009 DBMET00484 | DBMET00484 | |
| 0.001 | 0.818 | 0.048 | Carbonic anhydrase I inhibitor | 0.048 0.045 DBMET00484 | DBMET00484 | |
| 0.005 | 0.821 | 0.021 | Tryptophan hydroxylase 1 inhibitor | 0.021 0.006 DBMET00484 | DBMET00484 | |
| 0.007 | 0.824 | 0.092 | Prostaglandin F2 alpha antagonist | 0.092 0.015 DBMET00484 | DBMET00484 | |
| 0.004 | 0.821 | 0.245 | Lipoxygenase inhibitor | 0.245 0.103 DBMET00484 | DBMET00484 | |
| 0.003 | 0.821 | 0.071 | Beta adrenoreceptor antagonist | 0.071 0.037 DBMET00484 | DBMET00484 | |
| 0.012 | 0.83 | 0.169 | Vanilloid 1 agonist | 0.131 0.065 DBMET00328 0.169 0.024 DBMET00484 | DBMET00484 | |
| 0.003 | 0.821 | 0.045 | Glutamate (mGluR4) agonist | 0.045 0.013 DBMET00484 | DBMET00484 | |
| 0.002 | 0.822 | 0.045 | 1-Alkyl-2-acetylglycerophosphocholine esterase inhibitor | 0.045 0.012 DBMET00484 | DBMET00484 | |
| 0.005 | 0.828 | 0.146 | GABA B receptor agonist | 0.087 0.03 DBMET00328 0.146 0.004 DBMET00484 | DBMET00484 | |
| 0.006 | 0.829 | 0.165 | Carbonic anhydrase XIII inhibitor | 0.119 0.03 DBMET00328 0.165 0.019 DBMET00484 | DBMET00484 | |
| 0.002 | 0.826 | 0.028 | Prostaglandin EP3 antagonist | 0.028 0.023 DBMET00484 | DBMET00484 | |
| 0.004 | 0.829 | 0.129 | HIV-1 integrase inhibitor | 0.129 0.012 DBMET00484 | DBMET00484 | |
| 0.007 | 0.834 | 0.26 | Keratolytic | 0.087 0.041 DBMET00328 0.26 0.005 DBMET00484 | DBMET00484 | |
| 0.009 | 0.837 | 0.157 | Granulocyte macrophage colony stimulating factor agonist | 0.144 0.006 DBMET00328 0.157 0.005 DBMET00484 | DBMET00484 | |
| 0.005 | 0.834 | 0.397 | Hypolipemic | 0.397 0.026 DBMET00484 | DBMET00484 | |
| 0.002 | 0.833 | 0.669 | Porphobilinogen synthase inhibitor | 0.308 0.005 DBMET00328 0.669 0.003 DBMET00484 | DBMET00484 | |
| 0.002 | 0.832 | 0.032 | Inosine monophosphate dehydrogenase inhibitor | 0.032 0.031 DBMET00484 | DBMET00484 | |
| 0.005 | 0.835 | 0.09 | Bromodomain-containing protein 2 inhibitor | 0.09 0.055 DBMET00328 | DBMET00328 | |
| 0.001 | 0.832 | 0.102 | Carbonic anhydrase VB inhibitor | 0.102 0.016 DBMET00484 | DBMET00484 | |
| 0.008 | 0.839 | 0.091 | Topoisomerase II beta inhibitor | 0.091 0.011 DBMET00484 | DBMET00484 | |
| 0.001 | 0.832 | 0.032 | Nicotinic alpha4beta2 receptor agonist | 0.032 0.015 DBMET00328 | DBMET00328 | |
| 0.008 | 0.839 | 0.04 | Aggrecanase 1 inhibitor | 0.04 0.025 DBMET00484 | DBMET00484 | |
| 0.006 | 0.838 | 0.153 | Platelet aggregation inhibitor | 0.153 0.125 DBMET00484 | DBMET00484 | |
| 0.003 | 0.836 | 0.22 | Aminopeptidase I inhibitor | 0.125 0.018 DBMET00328 0.22 0.005 DBMET00484 | DBMET00484 | |
| 0.006 | 0.839 | 0.238 | Toll-Like receptor 2 antagonist | 0.158 0.047 DBMET00328 0.238 0.011 DBMET00484 | DBMET00484 | |
| 0.002 | 0.834 | 0.061 | Potassium channel Kv1.3 blocker | 0.042 0.039 DBMET00328 0.061 0.02 DBMET00484 | DBMET00484 | |
| 0.003 | 0.836 | 0.039 | Protocollagen prolyl hydroxylase inhibitor | 0.039 0.008 DBMET00484 | DBMET00484 | |
| 0.01 | 0.844 | 0.386 | NADH dehydrogenase inhibitor | 0.192 0.011 DBMET00328 0.386 0.005 DBMET00484 | DBMET00484 | |
| 0.013 | 0.847 | 0.187 | Antineoplastic alkaloid | 0.187 0.017 DBMET00484 | DBMET00484 | |
| 0.005 | 0.839 | 0.212 | Lipid peroxidase inhibitor | 0.212 0.037 DBMET00484 | DBMET00484 | |
| 0.003 | 0.839 | 0.054 | Integrin alpha2 antagonist | 0.054 0.01 DBMET00484 | DBMET00484 | |
| 0.001 | 0.837 | 0.018 | Nicotinic alpha4 receptor agonist | 0.018 0.009 DBMET00328 | DBMET00328 | |
| 0.007 | 0.845 | 0.084 | Dihydroorotate oxidase inhibitor | 0.072 0.016 DBMET00328 0.084 0.009 DBMET00484 | DBMET00484 | |
| 0.002 | 0.841 | 0.046 | Metalloproteinase-3 inhibitor | 0.046 0.037 DBMET00484 | DBMET00484 | |
| 0.001 | 0.841 | 0.053 | Carbonic anhydrase IV inhibitor | 0.053 0.023 DBMET00484 | DBMET00484 | |
| 0.013 | 0.853 | 0.261 | Photosensitizer | 0.154 0.029 DBMET00328 0.261 0.005 DBMET00484 | DBMET00484 | |
| 0.005 | 0.846 | 0.121 | Cyclooxygenase inhibitor | 0.121 0.097 DBMET00484 | DBMET00484 | |
| 0.003 | 0.845 | 0.189 | Aryl hydrocarbon receptor agonist | 0.145 0.14 DBMET00328 0.189 0.108 DBMET00484 | DBMET00484 | |
| 0.003 | 0.847 | 0.135 | Macrophage migration inhibitory factor inhibitor | 0.135 0.02 DBMET00484 | DBMET00484 | |
| 0.001 | 0.845 | 0.035 | 11-Beta-hydroxysteroid dehydrogenase 2 inhibitor | 0.035 0.014 DBMET00484 | DBMET00484 | |
| 0.001 | 0.846 | 0.081 | Ribonucleotide reductase inhibitor | 0.053 0.04 DBMET00328 0.081 0.026 DBMET00484 | DBMET00484 | |
| 0.007 | 0.853 | 0.313 | Thrombolytic | 0.313 0.022 DBMET00484 | DBMET00484 | |
| 0.003 | 0.849 | 0.173 | Cytidine deaminase inhibitor | 0.114 0.107 DBMET00328 0.173 0.06 DBMET00484 | DBMET00484 | |
| 0.002 | 0.848 | 0.05 | Integrin alpha4beta7 antagonist | 0.05 0.005 DBMET00484 | DBMET00484 | |
| 0.001 | 0.847 | 0.103 | Retinoid X receptor agonist | 0.031 0.028 DBMET00328 0.103 0.004 DBMET00484 | DBMET00484 | |
| 0.002 | 0.848 | 0.061 | Phosphorylase inhibitor | 0.061 0.024 DBMET00484 | DBMET00484 | |
| 0.001 | 0.849 | 0.044 | Nicotinic acid receptor 2 antagonist | 0.032 0.01 DBMET00328 0.044 0.004 DBMET00484 | DBMET00484 | |
| 0.002 | 0.85 | 0.059 | Matrix metalloproteinase inhibitor | 0.059 0.055 DBMET00484 | DBMET00484 | |
| 0.001 | 0.851 | 0.019 | Purinergic P2Y1 agonist | 0.016 0.01 DBMET00328 0.019 0.007 DBMET00484 | DBMET00484 | |
| 0.009 | 0.859 | 0.064 | Immunoglobulin Fc receptor antagonist | 0.061 0.022 DBMET00328 0.064 0.017 DBMET00484 | DBMET00484 | |
| 0.001 | 0.853 | 0.036 | Epoxide hydrolase 1 inhibitor | 0.03 0.023 DBMET00328 0.036 0.015 DBMET00484 | DBMET00484 | |
| 0.018 | 0.871 | 0.642 | 5 Hydroxytryptamine release inhibitor | 0.441 0.056 DBMET00328 0.642 0.007 DBMET00484 | DBMET00484 | |
| 0.008 | 0.861 | 0.154 | Carbonic anhydrase XV inhibitor | 0.114 0.052 DBMET00328 0.154 0.029 DBMET00484 | DBMET00484 | |
| 0.001 | 0.856 | 0.079 | Ribonucleoside-diphosphate reductase inhibitor | 0.053 0.039 DBMET00328 0.079 0.025 DBMET00484 | DBMET00484 | |
| 0.005 | 0.859 | 0.124 | Neuropeptide Y1 antagonist | 0.124 0.115 DBMET00328 | DBMET00328 | |
| 0.007 | 0.862 | 0.151 | Purinergic P2X1 antagonist | 0.117 0.012 DBMET00328 0.151 0.007 DBMET00484 | DBMET00484 | |
| 0.002 | 0.857 | 0.052 | Oxytocin agonist | 0.051 0.023 DBMET00328 0.052 0.022 DBMET00484 | DBMET00484 | |
| 0.004 | 0.86 | 0.561 | Ferrochelatase inhibitor | 0.367 0.004 DBMET00328 0.561 0.002 DBMET00484 | DBMET00484 | |
| 0.004 | 0.859 | 0.199 | Diuretic | 0.199 0.044 DBMET00484 | DBMET00484 | |
| 0 | 0.857 | 0.032 | Telomerase stimulant | 0.023 0.005 DBMET00328 0.032 0.003 DBMET00484 | DBMET00484 | |
| 0.003 | 0.862 | 0.176 | Aldose reductase inhibitor | 0.176 0.009 DBMET00484 | DBMET00484 | |
| 0.001 | 0.86 | 0.043 | Vanilloid 2 agonist | 0.034 0.006 DBMET00328 0.043 0.004 DBMET00484 | DBMET00484 | |
| 0.013 | 0.873 | 0.335 | Amylase inhibitor | 0.285 0.02 DBMET00328 0.335 0.014 DBMET00484 | DBMET00484 | |
| 0.005 | 0.865 | 0.272 | GABA C receptor rho-1 antagonist | 0.184 0.011 DBMET00328 0.272 0.004 DBMET00484 | DBMET00484 | |
| 0.01 | 0.87 | 0.24 | Cyclooxygenase 3 inhibitor | 0.137 0.06 DBMET00328 0.24 0.01 DBMET00484 | DBMET00484 | |
| 0.001 | 0.862 | 0.042 | Methionyl aminopeptidase 1 inhibitor | 0.042 0.01 DBMET00484 | DBMET00484 | |
| 0.014 | 0.875 | 0.357 | Gastrin inhibitor | 0.239 0.092 DBMET00328 0.357 0.009 DBMET00484 | DBMET00484 | |
| 0.003 | 0.864 | 0.122 | Alkaline phosphatase inhibitor | 0.122 0.083 DBMET00484 | DBMET00484 | |
| 0.036 | 0.897 | 0.477 | 5 Hydroxytryptamine uptake stimulant | 0.388 0.016 DBMET00328 0.477 0.005 DBMET00484 | DBMET00484 | |
| 0.002 | 0.864 | 0.039 | Integrin alpha2beta1 antagonist | 0.039 0.006 DBMET00484 | DBMET00484 | |
| 0.002 | 0.865 | 0.154 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.079 0.052 DBMET00328 0.154 0.017 DBMET00484 | DBMET00484 | |
| 0 | 0.863 | 0.018 | Angiotensin AT1B receptor antagonist | 0.018 0.007 DBMET00484 | DBMET00484 | |
| 0.008 | 0.872 | 0.198 | TRPA1 agonist | 0.198 0.011 DBMET00328 0.179 0.016 DBMET00484 | DBMET00328 | |
| 0.001 | 0.867 | 0.065 | Dihydropteroate synthase inhibitor | 0.065 0.01 DBMET00484 | DBMET00484 | |
| 0.005 | 0.871 | 0.111 | Beta glucuronidase inhibitor | 0.11 0.056 DBMET00328 0.111 0.055 DBMET00484 | DBMET00484 | |
| 0.019 | 0.886 | 0.218 | Ca2+-transporting ATPase inhibitor | 0.183 0.006 DBMET00328 0.218 0.002 DBMET00484 | DBMET00484 | |
| 0.001 | 0.869 | 0.078 | Thromboxane A2 antagonist | 0.078 0.016 DBMET00484 | DBMET00484 | |
| 0.002 | 0.871 | 0.024 | Thyroid hormone alpha agonist | 0.024 0.005 DBMET00484 | DBMET00484 | |
| 0.004 | 0.873 | 0.106 | Urease inhibitor | 0.087 0.081 DBMET00328 0.106 0.061 DBMET00484 | DBMET00484 | |
| 0.002 | 0.872 | 0.084 | Thromboxane antagonist | 0.084 0.018 DBMET00484 | DBMET00484 | |
| 0.002 | 0.872 | 0.13 | Xanthine dehydrogenase inhibitor | 0.13 0.009 DBMET00328 0.076 0.027 DBMET00484 | DBMET00328 | |
| 0.001 | 0.873 | 0.031 | Isoleucine-tRNA ligase inhibitor | 0.023 0.015 DBMET00328 0.031 0.005 DBMET00484 | DBMET00484 | |
| 0.002 | 0.875 | 0.05 | HMG CoA reductase inhibitor | 0.05 0.007 DBMET00484 | DBMET00484 | |
| 0.001 | 0.875 | 0.057 | Sphingosine 1-phosphate receptor 1 agonist | 0.057 0.014 DBMET00484 | DBMET00484 | |
| 0.001 | 0.875 | 0.071 | NMDA receptor subunit 3A antagonist | 0.071 0.014 DBMET00484 | DBMET00484 | |
| 0 | 0.875 | 0.022 | Thromboxane agonist | 0.022 0.004 DBMET00484 | DBMET00484 | |
| 0.007 | 0.882 | 0.172 | Anabolic | 0.144 0.021 DBMET00328 0.172 0.009 DBMET00484 | DBMET00484 | |
| 0 | 0.876 | 0.011 | Thyroid hormone beta agonist | 0.011 0.005 DBMET00484 | DBMET00484 | |
| 0.002 | 0.878 | 0.15 | Sphingosine 1-phosphate receptor 4 agonist | 0.075 0.04 DBMET00328 0.15 0.008 DBMET00484 | DBMET00484 | |
| 0.001 | 0.877 | 0.046 | Prostaglandin EP2 agonist | 0.046 0.007 DBMET00484 | DBMET00484 | |
| 0.002 | 0.878 | 0.033 | Peptide deformylase inhibitor | 0.027 0.025 DBMET00328 0.033 0.018 DBMET00484 | DBMET00484 | |
| 0.003 | 0.88 | 0.102 | Caspase 7 inhibitor | 0.102 0.026 DBMET00328 0.096 0.033 DBMET00484 | DBMET00328 | |
| 0.001 | 0.878 | 0.028 | Sodium/glucose cotransporter 2 inhibitor | 0.028 0.016 DBMET00484 | DBMET00484 | |
| 0.001 | 0.879 | 0.056 | Prostaglandin agonist | 0.056 0.009 DBMET00484 | DBMET00484 | |
| 0.01 | 0.89 | 0.049 | Carbonic anhydrase II stimulant | 0.049 0.042 DBMET00484 | DBMET00484 | |
| 0.003 | 0.883 | 0.029 | Complement factor 1s inhibitor | 0.029 0.01 DBMET00328 0.025 0.02 DBMET00484 | DBMET00328 | |
| 0.003 | 0.883 | 0.086 | Ryanodine receptor antagonist | 0.062 0.032 DBMET00328 0.086 0.006 DBMET00484 | DBMET00484 | |
| 0.001 | 0.882 | 0.041 | AMPA 1 receptor antagonist | 0.041 0.014 DBMET00484 | DBMET00484 | |
| 0 | 0.882 | 0.058 | Hypoxanthine phosphoribosyltransferase inhibitor | 0.058 0.007 DBMET00328 0.05 0.009 DBMET00484 | DBMET00328 | |
| 0.002 | 0.884 | 0.235 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.235 0.005 DBMET00328 0.219 0.006 DBMET00484 | DBMET00328 | |
| 0.022 | 0.905 | 0.166 | Glutamate release inhibitor | 0.12 0.022 DBMET00328 0.166 0.007 DBMET00484 | DBMET00484 | |
| 0.005 | 0.889 | 0.227 | Prolactin inhibitor | 0.182 0.012 DBMET00328 0.227 0.005 DBMET00484 | DBMET00484 | |
| 0.002 | 0.886 | 0.024 | Thyroid hormone alpha antagonist | 0.024 0.006 DBMET00484 | DBMET00484 | |
| 0.005 | 0.89 | 0.36 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.22 0.058 DBMET00328 0.36 0.011 DBMET00484 | DBMET00484 | |
| 0.001 | 0.886 | 0.025 | CXC chemokine 2 receptor antagonist | 0.025 0.02 DBMET00484 | DBMET00484 | |
| 0.001 | 0.887 | 0.031 | Estradiol 17 beta-dehydrogenase 3 inhibitor | 0.031 0.024 DBMET00484 | DBMET00484 | |
| 0.004 | 0.891 | 0.222 | Cell adhesion molecule inhibitor | 0.222 0.008 DBMET00484 | DBMET00484 | |
| 0 | 0.888 | 0.043 | Kainate receptor 1 antagonist | 0.043 0.006 DBMET00484 | DBMET00484 | |
| 0.004 | 0.892 | 0.256 | Arachidonic acid antagonist | 0.212 0.023 DBMET00328 0.256 0.005 DBMET00484 | DBMET00484 | |
| 0.001 | 0.889 | 0.048 | Peroxisome proliferator-activated receptor delta agonist | 0.048 0.013 DBMET00484 | DBMET00484 | |
| 0.005 | 0.894 | 0.223 | Cathepsin H inhibitor | 0.223 0.017 DBMET00328 0.183 0.028 DBMET00484 | DBMET00328 | |
| 0.01 | 0.899 | 0.139 | Lanosterol 14 alpha demethylase inhibitor | 0.115 0.035 DBMET00328 0.139 0.016 DBMET00484 | DBMET00484 | |
| 0.003 | 0.893 | 0.214 | 12-Lipoxygenase inhibitor | 0.214 0.136 DBMET00484 | DBMET00484 | |
| 0.003 | 0.893 | 0.017 | Integrin beta6 antagonist | 0.017 0.005 DBMET00484 | DBMET00484 | |
| 0.001 | 0.892 | 0.044 | Thyroid hormone agonist | 0.044 0.005 DBMET00484 | DBMET00484 | |
| 0.007 | 0.897 | 0.601 | Aldehyde dehydrogenase inhibitor | 0.601 0.004 DBMET00328 0.508 0.004 DBMET00484 | DBMET00328 | |
| 0.001 | 0.893 | 0.054 | Nerve growth factor antagonist | 0.048 0.02 DBMET00328 0.054 0.014 DBMET00484 | DBMET00484 | |
| 0.003 | 0.895 | 0.119 | GABA receptor agonist | 0.119 0.058 DBMET00484 | DBMET00484 | |
| 0.001 | 0.894 | 0.072 | Guanylate cyclase inhibitor | 0.058 0.014 DBMET00328 0.072 0.004 DBMET00484 | DBMET00484 | |
| 0.003 | 0.896 | 0.053 | Cytokine production stimulant | 0.053 0.023 DBMET00328 0.053 0.022 DBMET00484 | DBMET00484 | |
| 0.005 | 0.898 | 0.145 | Cyclooxygenase 1 inhibitor | 0.145 0.059 DBMET00484 | DBMET00484 | |
| 0.004 | 0.897 | 0.277 | Mannose-6-phosphate isomerase inhibitor | 0.277 0.008 DBMET00328 0.242 0.014 DBMET00484 | DBMET00328 | |
| 0.002 | 0.895 | 0.336 | Phenylalanine 4-hydroxylase inhibitor | 0.114 0.02 DBMET00328 0.336 0.004 DBMET00484 | DBMET00484 | |
| 0.001 | 0.895 | 0.065 | Leukotriene B4 antagonist | 0.065 0.023 DBMET00484 | DBMET00484 | |
| 0.002 | 0.896 | 0.059 | HCV NS3/NS4A protease inhibitor | 0.059 0.022 DBMET00328 0.058 0.023 DBMET00484 | DBMET00328 | |
| 0.005 | 0.899 | 0.516 | Platelet antagonist | 0.516 0.012 DBMET00484 | DBMET00484 | |
| 0.009 | 0.903 | 0.131 | D-Ala-D-Ala ligase inhibitor | 0.099 0.03 DBMET00328 0.131 0.009 DBMET00484 | DBMET00484 | |
| 0.001 | 0.895 | 0.017 | Alpha 2c adrenoreceptor agonist | 0.017 0.015 DBMET00328 | DBMET00328 | |
| 0.003 | 0.897 | 0.127 | CYP2A6 inhibitor | 0.127 0.024 DBMET00328 0.081 0.047 DBMET00484 | DBMET00328 | |
| 0.003 | 0.898 | 0.087 | Sphingosine 1-phosphate receptor antagonist | 0.087 0.034 DBMET00484 | DBMET00484 | |
| 0.029 | 0.924 | 0.533 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.533 0.021 DBMET00328 0.492 0.037 DBMET00484 | DBMET00328 | |
| 0 | 0.896 | 0.038 | Prostaglandin H2 antagonist | 0.038 0.007 DBMET00484 | DBMET00484 | |
| 0.001 | 0.897 | 0.072 | NMDA receptor subunit 3B antagonist | 0.072 0.015 DBMET00484 | DBMET00484 | |
| 0.001 | 0.898 | 0.056 | Angiotensin AT1 receptor antagonist | 0.056 0.01 DBMET00484 | DBMET00484 | |
| 0.003 | 0.899 | 0.058 | Histone deacetylase SIRT3 inhibitor | 0.058 0.056 DBMET00328 | DBMET00328 | |
| 0.002 | 0.899 | 0.126 | Prostaglandin D2 antagonist | 0.126 0.004 DBMET00484 | DBMET00484 | |
| 0.001 | 0.899 | 0.033 | HCV NS5B polymerase inhibitor | 0.033 0.02 DBMET00484 | DBMET00484 | |
| 0.002 | 0.901 | 0.177 | Amidase inhibitor | 0.177 0.007 DBMET00328 0.088 0.031 DBMET00484 | DBMET00328 | |
| 0.003 | 0.902 | 0.321 | Cystathionine beta-synthase inhibitor | 0.161 0.036 DBMET00328 0.321 0.008 DBMET00484 | DBMET00484 | |
| 0.001 | 0.9 | 0.038 | Carnitine palmitoyltransferase inhibitor | 0.038 0.018 DBMET00484 | DBMET00484 | |
| 0.001 | 0.902 | 0.045 | Angiotensin II receptor antagonist | 0.045 0.01 DBMET00484 | DBMET00484 | |
| 0.001 | 0.901 | 0.041 | Purinergic P2Y15 antagonist | 0.041 0.007 DBMET00328 0.041 0.006 DBMET00484 | DBMET00484 | |
| 0.005 | 0.906 | 0.315 | Cell adhesion inhibitor | 0.315 0.009 DBMET00484 | DBMET00484 | |
| 0.002 | 0.903 | 0.027 | ICAM 1 antagonist | 0.027 0.009 DBMET00484 | DBMET00484 | |
| 0.007 | 0.907 | 0.244 | Melanin inhibitor | 0.21 0.037 DBMET00328 0.244 0.029 DBMET00484 | DBMET00484 | |
| 0 | 0.902 | 0.033 | Prostaglandin E2 agonist | 0.033 0.009 DBMET00484 | DBMET00484 | |
| 0 | 0.902 | 0.064 | Uridine phosphorylase inhibitor | 0.034 0.015 DBMET00328 0.064 0.005 DBMET00484 | DBMET00484 | |
| 0.004 | 0.906 | 0.232 | 15-Lipoxygenase inhibitor | 0.232 0.18 DBMET00484 | DBMET00484 | |
| 0 | 0.903 | 0.028 | Ileal bile acid transport inhibitor | 0.028 0.005 DBMET00484 | DBMET00484 | |
| 0.003 | 0.906 | 0.062 | Heat shock protein 90 beta antagonist | 0.062 0.037 DBMET00484 | DBMET00484 | |
| 0.001 | 0.905 | 0.059 | Sphingosine 1-phosphate receptor agonist | 0.059 0.017 DBMET00484 | DBMET00484 | |
| 0.009 | 0.913 | 0.211 | Neuropeptide Y2 antagonist | 0.193 0.133 DBMET00328 0.211 0.101 DBMET00484 | DBMET00484 | |
| 0.001 | 0.904 | 0.049 | Farnesoid X receptor agonist | 0.049 0.015 DBMET00484 | DBMET00484 | |
| 0.002 | 0.906 | 0.035 | Melatonin receptor 1A agonist | 0.035 0.021 DBMET00328 0.034 0.022 DBMET00484 | DBMET00328 | |
| 0.002 | 0.907 | 0.064 | Beta 2 adrenoreceptor agonist | 0.064 0.036 DBMET00484 | DBMET00484 | |
| 0.031 | 0.936 | 0.263 | 5 Hydroxytryptamine 3E antagonist | 0.263 0.011 DBMET00328 0.211 0.047 DBMET00484 | DBMET00328 | |
| 0.003 | 0.91 | 0.104 | Glutamate (mGluR group III) antagonist | 0.041 0.038 DBMET00328 0.104 0.005 DBMET00484 | DBMET00484 | |
| 0.007 | 0.915 | 0.605 | Peroxidase inhibitor | 0.405 0.02 DBMET00328 0.605 0.004 DBMET00484 | DBMET00484 | |
| 0.001 | 0.908 | 0.041 | Carbonic anhydrase VII inhibitor | 0.041 0.039 DBMET00484 | DBMET00484 | |
| 0.002 | 0.91 | 0.078 | Carbonic anhydrase XIV inhibitor | 0.078 0.017 DBMET00484 | DBMET00484 | |
| 0.001 | 0.91 | 0.111 | Glutamate (mGluR3) antagonist | 0.111 0.004 DBMET00484 | DBMET00484 | |
| 0.002 | 0.911 | 0.042 | RNA-directed RNA polymerase inhibitor | 0.042 0.017 DBMET00484 | DBMET00484 | |
| 0.002 | 0.911 | 0.056 | Collagenase 3 inhibitor | 0.056 0.046 DBMET00484 | DBMET00484 | |
| 0.006 | 0.916 | 0.126 | Sphingomyelinase inhibitor | 0.102 0.058 DBMET00328 0.126 0.037 DBMET00484 | DBMET00484 | |
| 0.005 | 0.916 | 0.061 | Transcription factor AP-1 inhibitor | 0.061 0.044 DBMET00484 | DBMET00484 | |
| 0.003 | 0.914 | 0.337 | GABA C receptor antagonist | 0.212 0.011 DBMET00328 0.337 0.004 DBMET00484 | DBMET00484 | |
| 0.001 | 0.912 | 0.029 | Calcium-sensing receptor agonist | 0.029 0.015 DBMET00484 | DBMET00484 | |
| 0.004 | 0.915 | 0.25 | Transcription factor STAT3 inhibitor | 0.218 0.113 DBMET00328 0.25 0.083 DBMET00484 | DBMET00484 | |
| 0.002 | 0.914 | 0.33 | Psychostimulant | 0.169 0.101 DBMET00328 0.33 0.036 DBMET00484 | DBMET00484 | |
| 0.001 | 0.913 | 0.049 | AMPA 3 receptor antagonist | 0.049 0.009 DBMET00484 | DBMET00484 | |
| 0.003 | 0.916 | 0.124 | Heat shock protein 90 alpha antagonist | 0.124 0.12 DBMET00328 | DBMET00328 | |
| 0.029 | 0.942 | 0.326 | Nitric-oxide synthase stimulant | 0.263 0.025 DBMET00328 0.326 0.007 DBMET00484 | DBMET00484 | |
| 0.001 | 0.914 | 0.067 | Nicotinic acid receptor agonist | 0.067 0.009 DBMET00484 | DBMET00484 | |
| 0.002 | 0.915 | 0.212 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | 0.212 0.093 DBMET00484 | DBMET00484 | |
| 0.007 | 0.921 | 0.235 | ATPase inhibitor | 0.209 0.031 DBMET00328 0.235 0.018 DBMET00484 | DBMET00484 | |
| 0.001 | 0.916 | 0.026 | Sodium/glucose cotransporter inhibitor | 0.026 0.017 DBMET00484 | DBMET00484 | |
| 0.008 | 0.923 | 0.142 | Tumour necrosis factor antagonist | 0.142 0.11 DBMET00484 | DBMET00484 | |
| 0.004 | 0.92 | 0.245 | Neurotensin receptor agonist | 0.162 0.075 DBMET00328 0.245 0.022 DBMET00484 | DBMET00484 | |
| 0.004 | 0.922 | 0.107 | Glutamate (mGluR4) antagonist | 0.042 0.034 DBMET00328 0.107 0.005 DBMET00484 | DBMET00484 | |
| 0.002 | 0.92 | 0.069 | Metalloproteinase-9 inhibitor | 0.069 0.058 DBMET00484 | DBMET00484 | |
| 0.006 | 0.924 | 0.283 | Protein kinase stimulant | 0.127 0.086 DBMET00328 0.283 0.019 DBMET00484 | DBMET00484 | |
| 0.01 | 0.929 | 0.298 | Interferon gamma antagonist | 0.173 0.055 DBMET00328 0.298 0.02 DBMET00484 | DBMET00484 | |
| 0.001 | 0.921 | 0.05 | AMPA receptor antagonist | 0.05 0.031 DBMET00484 | DBMET00484 | |
| 0.001 | 0.921 | 0.084 | Kainate receptor 2 antagonist | 0.084 0.006 DBMET00484 | DBMET00484 | |
| 0.004 | 0.925 | 0.244 | Transcription factor STAT inhibitor | 0.198 0.141 DBMET00328 0.244 0.091 DBMET00484 | DBMET00484 | |
| 0.001 | 0.922 | 0.063 | NMDA 2A receptor antagonist | 0.063 0.028 DBMET00484 | DBMET00484 | |
| 0.001 | 0.923 | 0.04 | Nicotinic receptor alpha3 subunit antagonist | 0.04 0.036 DBMET00328 | DBMET00328 | |
| 0.012 | 0.935 | 0.168 | Interleukin 4 antagonist | 0.168 0.036 DBMET00484 | DBMET00484 | |
| 0.002 | 0.925 | 0.059 | Beta 1 adrenoreceptor antagonist | 0.059 0.037 DBMET00484 | DBMET00484 | |
| 0.001 | 0.924 | 0.123 | Retinoid X alpha receptor agonist | 0.032 0.027 DBMET00328 0.123 0.004 DBMET00484 | DBMET00484 | |
| 0.001 | 0.924 | 0.088 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.088 0.021 DBMET00484 | DBMET00484 | |
| 0.001 | 0.926 | 0.038 | LFA antagonist | 0.038 0.009 DBMET00484 | DBMET00484 | |
| 0.016 | 0.941 | 0.372 | Caspase 3 stimulant | 0.372 0.052 DBMET00328 0.233 0.129 DBMET00484 | DBMET00328 | |
| 0.001 | 0.926 | 0.095 | Dopamine D5 agonist | 0.06 0.012 DBMET00328 0.095 0.004 DBMET00484 | DBMET00484 | |
| 0.003 | 0.929 | 0.035 | Carbonic anhydrase I stimulant | 0.035 0.03 DBMET00484 | DBMET00484 | |
| 0.008 | 0.934 | 0.326 | Platelet adhesion inhibitor | 0.326 0.026 DBMET00484 | DBMET00484 | |
| 0.003 | 0.929 | 0.075 | Adenosine deaminase inhibitor | 0.07 0.014 DBMET00328 0.075 0.011 DBMET00484 | DBMET00484 | |
| 0.003 | 0.93 | 0.269 | Spasmolytic | 0.269 0.083 DBMET00484 | DBMET00484 | |
| 0 | 0.927 | 0.026 | 5-Alpha-reductase 1 inhibitor | 0.026 0.009 DBMET00484 | DBMET00484 | |
| 0.001 | 0.928 | 0.063 | Fructose-1,6-bisphosphatase inhibitor | 0.063 0.016 DBMET00484 | DBMET00484 | |
| 0.002 | 0.929 | 0.064 | Sphingosine 1-phosphate receptor 1 antagonist | 0.064 0.023 DBMET00484 | DBMET00484 | |
| 0.002 | 0.93 | 0.142 | Anesthetic local | 0.129 0.061 DBMET00328 0.142 0.053 DBMET00484 | DBMET00484 | |
| 0.001 | 0.929 | 0.033 | Protein kinase (CK2) beta inhibitor | 0.033 0.024 DBMET00484 | DBMET00484 | |
| 0.008 | 0.936 | 0.147 | Histone acetyltransferase inhibitor | 0.147 0.144 DBMET00484 | DBMET00484 | |
| 0.008 | 0.937 | 0.132 | Glutamate (mGluR7) agonist | 0.104 0.051 DBMET00328 0.132 0.021 DBMET00484 | DBMET00484 | |
| 0.001 | 0.93 | 0.02 | Protease (Human cytomegalovirus) inhibitor | 0.02 0.018 DBMET00484 | DBMET00484 | |
| 0 | 0.93 | 0.03 | Fructose-1,6-bisphosphatase 1 inhibitor | 0.03 0.008 DBMET00484 | DBMET00484 | |
| 0.001 | 0.931 | 0.059 | Squalene epoxidase inhibitor | 0.059 0.021 DBMET00328 0.058 0.023 DBMET00484 | DBMET00328 | |
| 0.001 | 0.931 | 0.056 | Prostaglandin F2 alpha agonist | 0.023 0.014 DBMET00328 0.056 0.004 DBMET00484 | DBMET00484 | |
| 0.001 | 0.932 | 0.049 | Glutamate (mGluR group I) agonist | 0.049 0.031 DBMET00328 0.042 0.04 DBMET00484 | DBMET00328 | |
| 0.002 | 0.933 | 0.075 | AICAR transformylase inhibitor | 0.066 0.011 DBMET00328 0.075 0.008 DBMET00484 | DBMET00484 | |
| 0 | 0.932 | 0.081 | Urate transporter 1 inhibitor | 0.081 0.008 DBMET00484 | DBMET00484 | |
| 0.002 | 0.933 | 0.072 | Heparanase inhibitor | 0.054 0.034 DBMET00328 0.072 0.01 DBMET00484 | DBMET00484 | |
| 0.016 | 0.948 | 0.437 | Calcium channel activator | 0.344 0.054 DBMET00328 0.437 0.014 DBMET00484 | DBMET00484 | |
| 0.003 | 0.935 | 0.312 | Creatine kinase inhibitor | 0.186 0.013 DBMET00328 0.312 0.004 DBMET00484 | DBMET00484 | |
| 0.005 | 0.937 | 0.279 | GABA C receptor rho-2 antagonist | 0.237 0.014 DBMET00328 0.279 0.007 DBMET00484 | DBMET00484 | |
| 0.004 | 0.937 | 0.74 | Aldehyde oxidase inhibitor | 0.586 0.021 DBMET00328 0.74 0.006 DBMET00484 | DBMET00484 | |
| 0.006 | 0.939 | 0.122 | Exportin-1 inhibitor | 0.117 0.005 DBMET00328 0.122 0.004 DBMET00484 | DBMET00484 | |
| 0.001 | 0.935 | 0.075 | 5-Alpha-reductase inhibitor | 0.075 0.013 DBMET00484 | DBMET00484 | |
| 0.001 | 0.935 | 0.051 | Leukotriene C4 antagonist | 0.051 0.01 DBMET00484 | DBMET00484 | |
| 0.001 | 0.935 | 0.038 | Carnitine palmitoyltransferase 1 inhibitor | 0.038 0.018 DBMET00484 | DBMET00484 | |
| 0.001 | 0.936 | 0.029 | 5-Alpha-reductase 2 inhibitor | 0.029 0.009 DBMET00484 | DBMET00484 | |
| 0.001 | 0.936 | 0.086 | AMPA 4 receptor antagonist | 0.086 0.006 DBMET00484 | DBMET00484 | |
| 0 | 0.936 | 0.016 | Egl nine homolog 3 inhibitor | 0.016 0.005 DBMET00484 | DBMET00484 | |
| 0.003 | 0.939 | 0.303 | Non-steroidal antiinflammatory agent | 0.198 0.073 DBMET00328 0.303 0.028 DBMET00484 | DBMET00484 | |
| 0.001 | 0.937 | 0.089 | Leukotriene antagonist | 0.089 0.027 DBMET00484 | DBMET00484 | |
| 0.004 | 0.94 | 0.092 | MAP kinase kinase 7 inhibitor | 0.081 0.043 DBMET00328 0.092 0.021 DBMET00484 | DBMET00484 | |
| 0.008 | 0.944 | 0.203 | Hexokinase inhibitor | 0.2 0.035 DBMET00328 0.203 0.033 DBMET00484 | DBMET00484 | |
| 0.001 | 0.938 | 0.032 | Prostaglandin EP4 antagonist | 0.032 0.014 DBMET00484 | DBMET00484 | |
| 0.008 | 0.946 | 0.592 | GABA C receptor rho-3 antagonist | 0.567 0.012 DBMET00328 0.592 0.008 DBMET00484 | DBMET00484 | |
| 0.001 | 0.938 | 0.086 | NMDA 2C receptor antagonist | 0.086 0.021 DBMET00484 | DBMET00484 | |
| 0.001 | 0.939 | 0.05 | Liver X receptor alpha agonist | 0.05 0.019 DBMET00484 | DBMET00484 | |
| 0 | 0.938 | 0.007 | DNA topoisomerase III inhibitor | 0.007 0.005 DBMET00328 0.007 0.006 DBMET00484 | DBMET00484 | |
| 0.001 | 0.94 | 0.058 | GABA B receptor antagonist | 0.058 0.014 DBMET00484 | DBMET00484 | |
| 0.002 | 0.941 | 0.038 | Ceramide glucosyltransferase inhibitor | 0.038 0.02 DBMET00484 | DBMET00484 | |
| 0.01 | 0.949 | 0.068 | Calcium channel P-type blocker | 0.063 0.045 DBMET00328 0.068 0.033 DBMET00484 | DBMET00484 | |
| 0.004 | 0.943 | 0.186 | Thyroid hormone antagonist | 0.186 0.174 DBMET00484 | DBMET00484 | |
| 0.013 | 0.953 | 0.551 | Tyrosine 3 hydroxylase inhibitor | 0.358 0.014 DBMET00328 0.551 0.003 DBMET00484 | DBMET00484 | |
| 0.002 | 0.941 | 0.038 | CF transmembrane conductance regulator antagonist | 0.038 0.035 DBMET00484 | DBMET00484 | |
| 0.001 | 0.941 | 0.084 | Glutamate receptor agonist | 0.084 0.049 DBMET00484 | DBMET00484 | |
| 0.002 | 0.942 | 0.029 | Glucosylceramidase stimulant | 0.029 0.013 DBMET00328 | DBMET00328 | |
| 0 | 0.941 | 0.032 | Thromboxane A2 agonist | 0.018 0.007 DBMET00328 0.032 0.003 DBMET00484 | DBMET00484 | |
| 0.003 | 0.943 | 0.059 | 5 Hydroxytryptamine 3 agonist | 0.059 0.05 DBMET00328 | DBMET00328 | |
| 0.001 | 0.942 | 0.074 | Leukotriene C antagonist | 0.074 0.011 DBMET00484 | DBMET00484 | |
| 0.002 | 0.944 | 0.057 | Tryptophan 5 hydroxylase inhibitor | 0.034 0.032 DBMET00328 0.057 0.004 DBMET00484 | DBMET00484 | |
| 0.005 | 0.947 | 0.13 | Bile acid receptor antagonist | 0.086 0.083 DBMET00328 0.13 0.013 DBMET00484 | DBMET00484 | |
| 0.002 | 0.944 | 0.359 | Alcohol dehydrogenase inhibitor | 0.359 0.004 DBMET00328 0.254 0.007 DBMET00484 | DBMET00328 | |
| 0.004 | 0.947 | 0.361 | Transcription factor NF kappa B inhibitor | 0.29 0.1 DBMET00328 0.361 0.074 DBMET00484 | DBMET00484 | |
| 0.007 | 0.95 | 0.571 | Superoxide dismutase inhibitor | 0.571 0.008 DBMET00328 0.546 0.009 DBMET00484 | DBMET00328 | |
| 0.001 | 0.944 | 0.026 | Acid ceramidase inhibitor | 0.026 0.017 DBMET00328 | DBMET00328 | |
| 0.014 | 0.958 | 0.173 | Heat shock protein 70 antagonist | 0.145 0.059 DBMET00328 0.173 0.015 DBMET00484 | DBMET00484 | |
| 0.007 | 0.951 | 0.198 | CF transmembrane conductance regulator agonist | 0.177 0.039 DBMET00328 0.198 0.023 DBMET00484 | DBMET00484 | |
| 0.002 | 0.947 | 0.057 | Fatty acid synthase inhibitor | 0.057 0.04 DBMET00484 | DBMET00484 | |
| 0.002 | 0.946 | 0.088 | NMDA receptor antagonist | 0.088 0.056 DBMET00484 | DBMET00484 | |
| 0.002 | 0.946 | 0.043 | Beta adrenoreceptor agonist | 0.043 0.041 DBMET00484 | DBMET00484 | |
| 0.001 | 0.946 | 0.041 | Glutamate (mGluR1a) antagonist | 0.041 0.028 DBMET00484 | DBMET00484 | |
| 0.001 | 0.946 | 0.047 | Dihydrofolate reductase inhibitor | 0.047 0.023 DBMET00484 | DBMET00484 | |
| 0.008 | 0.953 | 0.152 | Estrogen-related receptor beta agonist | 0.106 0.018 DBMET00328 0.152 0.004 DBMET00484 | DBMET00484 | |
| 0 | 0.946 | 0.018 | 1-Deoxy-D-xylulose-5-phosphate reductoisomerase inhibitor | 0.015 0.007 DBMET00328 0.018 0.005 DBMET00484 | DBMET00484 | |
| 0.003 | 0.949 | 0.21 | Sphingosine 1-phosphate receptor 5 antagonist | 0.15 0.061 DBMET00328 0.21 0.008 DBMET00484 | DBMET00484 | |
| 0.001 | 0.948 | 0.06 | ATP citrate lysase inhibitor | 0.06 0.005 DBMET00484 | DBMET00484 | |
| 0 | 0.948 | 0.025 | G-protein-coupled receptor 120 agonist | 0.025 0.006 DBMET00484 | DBMET00484 | |
| 0 | 0.948 | 0.013 | Integrin beta2 antagonist | 0.013 0.008 DBMET00484 | DBMET00484 | |
| 0.002 | 0.95 | 0.088 | MAP kinase kinase 1 inhibitor | 0.088 0.073 DBMET00484 | DBMET00484 | |
| 0 | 0.949 | 0.028 | Potassium channel small-conductance Ca-activated activator | 0.028 0.026 DBMET00328 | DBMET00328 | |
| 0.002 | 0.951 | 0.066 | Beta 3 adrenoreceptor antagonist | 0.066 0.041 DBMET00484 | DBMET00484 | |
| 0 | 0.95 | 0.017 | Complement factor D inhibitor | 0.017 0.015 DBMET00484 | DBMET00484 | |
| 0.002 | 0.952 | 0.06 | Diacylglycerol O-acyltransferase 1 inhibitor | 0.06 0.007 DBMET00484 | DBMET00484 | |
| 0.004 | 0.954 | 0.058 | Bombesin 2 receptor antagonist | 0.058 0.025 DBMET00484 | DBMET00484 | |
| 0.003 | 0.954 | 0.252 | Adenylate cyclase stimulant | 0.177 0.029 DBMET00328 0.252 0.004 DBMET00484 | DBMET00484 | |
| 0.012 | 0.963 | 0.557 | Histamine release inhibitor | 0.359 0.096 DBMET00328 0.557 0.015 DBMET00484 | DBMET00484 | |
| 0.002 | 0.953 | 0.223 | 5 Hydroxytryptamine 1E antagonist | 0.223 0.105 DBMET00328 | DBMET00328 | |
| 0.002 | 0.954 | 0.264 | Cholesterol synthesis inhibitor | 0.186 0.03 DBMET00328 0.264 0.016 DBMET00484 | DBMET00484 | |
| 0.001 | 0.953 | 0.102 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.093 0.019 DBMET00328 0.102 0.012 DBMET00484 | DBMET00484 | |
| 0.001 | 0.954 | 0.051 | Beta 2 adrenoreceptor antagonist | 0.051 0.034 DBMET00484 | DBMET00484 | |
| 0 | 0.954 | 0.03 | Nicotinic alpha3beta4 receptor agonist | 0.03 0.021 DBMET00328 | DBMET00328 | |
| 0 | 0.954 | 0.017 | Egl nine homolog 1 inhibitor | 0.017 0.008 DBMET00484 | DBMET00484 | |
| 0.002 | 0.956 | 0.145 | Mediator release inhibitor | 0.145 0.031 DBMET00484 | DBMET00484 | |
| 0.004 | 0.958 | 0.094 | mTOR complex 2 inhibitor | 0.091 0.046 DBMET00328 0.094 0.041 DBMET00484 | DBMET00484 | |
| 0.01 | 0.965 | 0.654 | Caspase 9 stimulant | 0.446 0.085 DBMET00328 0.654 0.029 DBMET00484 | DBMET00484 | |
| 0.011 | 0.966 | 0.445 | Interleukin agonist | 0.246 0.081 DBMET00328 0.445 0.013 DBMET00484 | DBMET00484 | |
| 0.001 | 0.957 | 0.073 | Geranyltranstransferase inhibitor | 0.073 0.006 DBMET00328 0.071 0.007 DBMET00484 | DBMET00328 | |
| 0 | 0.957 | 0.061 | Alpha 1d adrenoreceptor agonist | 0.061 0.01 DBMET00328 0.042 0.023 DBMET00484 | DBMET00328 | |
| 0.004 | 0.961 | 0.065 | Transcription factor RelA inhibitor | 0.065 0.039 DBMET00328 0.063 0.046 DBMET00484 | DBMET00328 | |
| 0.001 | 0.959 | 0.097 | Pregnane X receptor antagonist | 0.08 0.006 DBMET00328 0.097 0.004 DBMET00484 | DBMET00484 | |
| 0.001 | 0.958 | 0.053 | Glutamate (mGluR1) antagonist | 0.053 0.045 DBMET00484 | DBMET00484 | |
| 0.003 | 0.961 | 0.128 | Potassium channel (Ca-activated) activator | 0.128 0.037 DBMET00484 | DBMET00484 | |
| 0.001 | 0.959 | 0.043 | MAP3K5 inhibitor | 0.043 0.021 DBMET00484 | DBMET00484 | |
| 0.002 | 0.96 | 0.075 | Botulinum neurotoxin type A inhibitor | 0.075 0.02 DBMET00484 | DBMET00484 | |
| 0.002 | 0.96 | 0.113 | Inducible nitric-oxide synthase inhibitor | 0.113 0.028 DBMET00484 | DBMET00484 | |
| 0.001 | 0.959 | 0.075 | Prostaglandin-E synthase inhibitor | 0.075 0.043 DBMET00484 | DBMET00484 | |
| 0.002 | 0.96 | 0.068 | Protein kinase C beta inhibitor | 0.063 0.062 DBMET00328 0.068 0.052 DBMET00484 | DBMET00484 | |
| 0.003 | 0.961 | 0.028 | Liver X receptor alpha antagonist | 0.028 0.021 DBMET00484 | DBMET00484 | |
| 0.002 | 0.961 | 0.082 | Myeloperoxidase inhibitor | 0.082 0.063 DBMET00484 | DBMET00484 | |
| 0.001 | 0.96 | 0.035 | Liver X receptor beta agonist | 0.035 0.02 DBMET00484 | DBMET00484 | |
| 0.001 | 0.96 | 0.036 | Estrogen-related receptor gamma antagonist | 0.03 0.016 DBMET00328 0.036 0.008 DBMET00484 | DBMET00484 | |
| 0.001 | 0.96 | 0.048 | Benzodiazepine antagonist | 0.048 0.032 DBMET00484 | DBMET00484 | |
| 0 | 0.96 | 0.033 | G protein-coupled receptor agonist | 0.033 0.031 DBMET00484 | DBMET00484 | |
| 0.004 | 0.964 | 0.125 | MAP kinase 3 inhibitor | 0.125 0.12 DBMET00484 | DBMET00484 | |
| 0.001 | 0.961 | 0.058 | Sphingosine kinase 2 inhibitor | 0.052 0.044 DBMET00328 0.058 0.034 DBMET00484 | DBMET00484 | |
| 0.001 | 0.961 | 0.027 | Thymidine phosphorylase inhibitor | 0.024 0.022 DBMET00328 0.027 0.017 DBMET00484 | DBMET00484 | |
| 0 | 0.961 | 0.025 | Estrogen-related receptor gamma agonist | 0.025 0.005 DBMET00484 | DBMET00484 | |
| 0.002 | 0.963 | 0.077 | Estrogen receptor alpha antagonist | 0.077 0.054 DBMET00484 | DBMET00484 | |
| 0.004 | 0.965 | 0.062 | Acetyl-CoA transferase 2 inhibitor | 0.062 0.028 DBMET00484 | DBMET00484 | |
| 0.001 | 0.962 | 0.045 | Potassium channel Kv1.1 blocker | 0.045 0.017 DBMET00328 | DBMET00328 | |
| 0.004 | 0.965 | 0.169 | NADPH oxidase inhibitor | 0.169 0.045 DBMET00328 0.138 0.064 DBMET00484 | DBMET00328 | |
| 0 | 0.962 | 0.014 | Integrin alphaVbeta6 antagonist | 0.014 0.01 DBMET00484 | DBMET00484 | |
| 0.001 | 0.962 | 0.055 | Histamine H2 receptor agonist | 0.055 0.018 DBMET00328 0.042 0.031 DBMET00484 | DBMET00328 | |
| 0.005 | 0.967 | 0.232 | HIV-1 integrase (Overall Integration) inhibitor | 0.103 0.052 DBMET00328 0.232 0.006 DBMET00484 | DBMET00484 | |
| 0 | 0.962 | 0.067 | Free fatty acid receptor 1 antagonist | 0.067 0.005 DBMET00484 | DBMET00484 | |
| 0.006 | 0.968 | 0.1 | Nav1.3 sodium channel blocker | 0.1 0.097 DBMET00328 | DBMET00328 | |
| 0.002 | 0.964 | 0.076 | Cyclin D1 inhibitor | 0.076 0.022 DBMET00328 | DBMET00328 | |
| 0.001 | 0.964 | 0.141 | 5 Hydroxytryptamine 3A agonist | 0.141 0.04 DBMET00328 0.102 0.074 DBMET00484 | DBMET00328 | |
| 0.001 | 0.965 | 0.055 | Vanilloid 3 antagonist | 0.038 0.026 DBMET00328 0.055 0.006 DBMET00484 | DBMET00484 | |
| 0.003 | 0.967 | 0.298 | Cyclic AMP phosphodiesterase inhibitor | 0.159 0.138 DBMET00328 0.298 0.043 DBMET00484 | DBMET00484 | |
| 0.001 | 0.965 | 0.063 | Lysophosphatidic acid 2 receptor antagonist | 0.063 0.006 DBMET00484 | DBMET00484 | |
| 0.001 | 0.966 | 0.072 | Thymidine kinase inhibitor | 0.039 0.031 DBMET00328 0.072 0.01 DBMET00484 | DBMET00484 | |
| 0.001 | 0.966 | 0.075 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.068 0.023 DBMET00328 0.075 0.019 DBMET00484 | DBMET00484 | |
| 0.001 | 0.966 | 0.087 | TRPA1 antagonist | 0.087 0.022 DBMET00328 | DBMET00328 | |
| 0.01 | 0.975 | 0.088 | CC chemokine 5 receptor agonist | 0.088 0.04 DBMET00328 0.086 0.047 DBMET00484 | DBMET00328 | |
| 0.001 | 0.966 | 0.034 | Cholesterol ester transfer protein antagonist | 0.034 0.018 DBMET00484 | DBMET00484 | |
| 0.004 | 0.97 | 0.132 | Transcription factor STAT6 inhibitor | 0.103 0.097 DBMET00328 0.132 0.042 DBMET00484 | DBMET00484 | |
| 0.001 | 0.967 | 0.07 | Sphingosine kinase inhibitor | 0.067 0.028 DBMET00328 0.07 0.025 DBMET00484 | DBMET00484 | |
| 0.001 | 0.967 | 0.097 | Nicotinic alpha4beta2 receptor antagonist | 0.097 0.034 DBMET00328 0.074 0.057 DBMET00484 | DBMET00328 | |
| 0.001 | 0.966 | 0.073 | Thymidylate synthase inhibitor | 0.051 0.026 DBMET00328 0.073 0.01 DBMET00484 | DBMET00484 | |
| 0.001 | 0.967 | 0.05 | Potassium channel (ATP-sensitive) activator | 0.05 0.03 DBMET00328 0.048 0.033 DBMET00484 | DBMET00328 | |
| 0.001 | 0.967 | 0.052 | Potassium channel (Inward rectifier) activator | 0.052 0.031 DBMET00328 0.051 0.034 DBMET00484 | DBMET00328 | |
| 0.002 | 0.969 | 0.099 | MDM2 inhibitor | 0.066 0.051 DBMET00328 0.099 0.007 DBMET00484 | DBMET00484 | |
| 0.001 | 0.968 | 0.07 | Glucosylceramidase inhibitor | 0.07 0.022 DBMET00328 0.053 0.041 DBMET00484 | DBMET00328 | |
| 0.001 | 0.968 | 0.105 | Histamine N-methyltransferase inhibitor | 0.091 0.054 DBMET00328 0.105 0.041 DBMET00484 | DBMET00484 | |
| 0.001 | 0.968 | 0.052 | Epithelial sodium channel blocker | 0.052 0.043 DBMET00484 | DBMET00484 | |
| 0.012 | 0.979 | 0.078 | Ca(v)3.1 blocker | 0.078 0.065 DBMET00328 | DBMET00328 | |
| 0.001 | 0.969 | 0.118 | Carbonic anhydrase stimulant | 0.058 0.043 DBMET00328 0.118 0.015 DBMET00484 | DBMET00484 | |
| 0.001 | 0.969 | 0.08 | Potassium channel (Tandem pore domain) blocker | 0.08 0.035 DBMET00328 0.075 0.049 DBMET00484 | DBMET00328 | |
| 0.002 | 0.97 | 0.033 | Hedgehog signaling activator | 0.031 0.012 DBMET00328 0.033 0.008 DBMET00484 | DBMET00484 | |
| 0.001 | 0.969 | 0.044 | Sphingosine kinase 1 inhibitor | 0.044 0.024 DBMET00484 | DBMET00484 | |
| 0.001 | 0.969 | 0.029 | Thymidine kinase (Herpes simplex virus 1) inhibitor | 0.026 0.02 DBMET00328 0.029 0.013 DBMET00484 | DBMET00484 | |
| 0 | 0.969 | 0.04 | Glutamate (mGluR group II) antagonist | 0.04 0.024 DBMET00484 | DBMET00484 | |
| 0 | 0.97 | 0.02 | Vitamin D receptor agonist | 0.02 0.007 DBMET00484 | DBMET00484 | |
| 0.003 | 0.972 | 0.132 | Acetylcholine release stimulant | 0.12 0.048 DBMET00328 0.132 0.031 DBMET00484 | DBMET00484 | |
| 0.002 | 0.972 | 0.109 | Nitric-oxide synthase inhibitor | 0.109 0.047 DBMET00484 | DBMET00484 | |
| 0.001 | 0.972 | 0.19 | Sphingosine 1-phosphate receptor 2 antagonist | 0.138 0.059 DBMET00328 0.19 0.01 DBMET00484 | DBMET00484 | |
| 0.003 | 0.974 | 0.309 | Neurotrophic factor enhancer | 0.216 0.062 DBMET00328 0.309 0.016 DBMET00484 | DBMET00484 | |
| 0.004 | 0.975 | 0.494 | Vasodilator, peripheral | 0.221 0.153 DBMET00328 0.494 0.029 DBMET00484 | DBMET00484 | |
| 0.003 | 0.974 | 0.053 | Nicotinic alpha3beta2 receptor antagonist | 0.052 0.04 DBMET00328 0.053 0.037 DBMET00484 | DBMET00484 | |
| 0 | 0.971 | 0.05 | Liver X receptor beta antagonist | 0.05 0.008 DBMET00484 | DBMET00484 | |
| 0.002 | 0.973 | 0.121 | AMP-activated protein kinase stimulant | 0.121 0.048 DBMET00484 | DBMET00484 | |
| 0.001 | 0.973 | 0.139 | Interferon agonist | 0.104 0.026 DBMET00328 0.139 0.012 DBMET00484 | DBMET00484 | |
| 0.002 | 0.974 | 0.11 | Vanilloid 4 agonist | 0.098 0.019 DBMET00328 0.11 0.011 DBMET00484 | DBMET00484 | |
| 0 | 0.972 | 0.049 | Histamine H1 receptor agonist | 0.049 0.02 DBMET00328 | DBMET00328 | |
| 0.002 | 0.974 | 0.114 | Nav1.6 sodium channel blocker | 0.114 0.105 DBMET00328 0.112 0.109 DBMET00484 | DBMET00328 | |
| 0.002 | 0.973 | 0.109 | Interferon inducer | 0.064 0.045 DBMET00328 0.109 0.009 DBMET00484 | DBMET00484 | |
| 0.001 | 0.974 | 0.115 | Phospholipase D inhibitor | 0.091 0.021 DBMET00328 0.115 0.008 DBMET00484 | DBMET00484 | |
| 0.001 | 0.974 | 0.096 | Protein kinase C gamma inhibitor | 0.096 0.085 DBMET00484 | DBMET00484 | |
| 0 | 0.973 | 0.02 | Alpha 2b adrenoreceptor agonist | 0.02 0.01 DBMET00328 | DBMET00328 | |
| 0.004 | 0.978 | 0.169 | Interleukin antagonist | 0.169 0.104 DBMET00484 | DBMET00484 | |
| 0.005 | 0.979 | 0.402 | Cyclophilin D inhibitor | 0.402 0.089 DBMET00484 | DBMET00484 | |
| 0.001 | 0.975 | 0.049 | Glycine transporter 2 inhibitor | 0.049 0.031 DBMET00484 | DBMET00484 | |
| 0.013 | 0.988 | 0.627 | 5 Hydroxytryptamine release stimulant | 0.477 0.031 DBMET00328 0.627 0.012 DBMET00484 | DBMET00484 | |
| 0.002 | 0.977 | 0.104 | Gastric antisecretory | 0.104 0.061 DBMET00484 | DBMET00484 | |
| 0.002 | 0.978 | 0.219 | Adenylate cyclase inhibitor | 0.219 0.023 DBMET00484 | DBMET00484 | |
| 0.001 | 0.977 | 0.166 | Pregnane X receptor agonist | 0.146 0.061 DBMET00328 0.166 0.03 DBMET00484 | DBMET00484 | |
| 0.001 | 0.976 | 0.096 | Adenylate cyclase 1 inhibitor | 0.065 0.014 DBMET00328 0.096 0.005 DBMET00484 | DBMET00484 | |
| 0 | 0.976 | 0.009 | Integrin alpha5beta6 antagonist | 0.009 0.003 DBMET00484 | DBMET00484 | |
| 0.005 | 0.981 | 0.261 | Antiinflammatory | 0.261 0.255 DBMET00484 | DBMET00484 | |
| 0.001 | 0.978 | 0.083 | Diacylglycerol O-acyltransferase inhibitor | 0.083 0.013 DBMET00484 | DBMET00484 | |
| 0.003 | 0.98 | 0.164 | Hemostatic | 0.164 0.053 DBMET00484 | DBMET00484 | |
| 0.001 | 0.978 | 0.044 | Heme oxygenase inhibitor | 0.041 0.037 DBMET00328 0.044 0.025 DBMET00484 | DBMET00484 | |
| 0.005 | 0.982 | 0.287 | Insulin secretagoues | 0.287 0.014 DBMET00484 | DBMET00484 | |
| 0.003 | 0.982 | 0.055 | p53 inhibitor | 0.055 0.011 DBMET00484 | DBMET00484 | |
| 0 | 0.98 | 0.039 | Glucagon receptor antagonist | 0.039 0.014 DBMET00484 | DBMET00484 | |
| 0.001 | 0.981 | 0.054 | Aldosterone antagonist | 0.054 0.024 DBMET00484 | DBMET00484 | |
| 0.001 | 0.981 | 0.06 | Purinergic P2Y antagonist | 0.06 0.019 DBMET00484 | DBMET00484 | |
| 0.003 | 0.984 | 0.164 | Interleukin 8 antagonist | 0.164 0.026 DBMET00484 | DBMET00484 | |
| 0 | 0.982 | 0.024 | Thymidine kinase (Herpes simplex virus 2) inhibitor | 0.02 0.015 DBMET00328 0.024 0.008 DBMET00484 | DBMET00484 | |
| 0.002 | 0.985 | 0.16 | Antipruritic | 0.16 0.083 DBMET00484 | DBMET00484 | |
| 0.001 | 0.983 | 0.094 | Androgen agonist | 0.057 0.045 DBMET00328 0.094 0.017 DBMET00484 | DBMET00484 | |
| 0.002 | 0.984 | 0.062 | Corticotropin releasing factor 2 receptor antagonist | 0.062 0.042 DBMET00328 0.059 0.048 DBMET00484 | DBMET00328 | |
| 0.001 | 0.984 | 0.097 | Androgen antagonist | 0.097 0.049 DBMET00484 | DBMET00484 | |
| 0.002 | 0.985 | 0.107 | Phosphodiesterase 6D inhibitor | 0.107 0.04 DBMET00484 | DBMET00484 | |
| 0.004 | 0.993 | 0.163 | Interleukin 6 antagonist | 0.163 0.072 DBMET00484 | DBMET00484 | |
| 0.001 | 0.992 | 0.125 | Beta amyloid protein antagonist | 0.125 0.063 DBMET00484 | DBMET00484 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |